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Anthropological geneticists have applied methods and theories used in the 
analyses of normal variation to study complex diseases and their associated risk 
factors. This dissertation is an investigation of blood pressure (BP) and its correlation 
with metabolic syndrome (MS)-related traits using a cohort of Mexican American 
children. The major goals of this dissertation are to: (1) examine various MS-related 
traits in Mexican American children such as obesity, dyslipidemia, hypertension, 
impaired fasting glucose, impaired glucose tolerance, insulin resistance, and 
microalbuminuria; (2) determine the genetic influences on measures of systolic blood 
pressure (SBP), diastolic blood pressure (DBP) and other variables (e.g., fasting
insulin, fasting glucose, microalbuminuria, lipids, and adiposity measures) by 
estimating heritabilities; (3) examine  common genetic influences (i.e., pleiotropy) on 
BP and its related MS-related traits (e.g., obesity) by using bivariate analyses; and, 
(4) investigate potential genetic-by-environment (e.g., obesity and lifestyle factors 
such as physical activity) interaction influences on BP. This study examined 604 
nondiabetic Mexican American children and adolescents aged 6-17 years. Variance 
component analysis is used for both univariate and multivariate models to partition 
the total phenotypic variation of a given trait(s) into genetic and environmental 
components. The results indicate high to moderate occurrence of various MS risk 
factors in these children (overweight = 52%, obesity = 33%, low HDL = 24%, 
prediabetes = 15%, increased abdominal obesity = 14%, and high blood pressure = 
13%). These findings signify the increasing burden of disease risk in these children 
due to elevated BP, higher prevalence of obesity, and lower insulin sensitivity. The 
heritabilities of SBP, DBP, and elevated BP are high in this population, suggesting 
that additive genetic factors strongly influence BP. The relative contributions of both 
genetic and environmental influence were quantified, genes accounted for 25 - 85% 
of the phenotypic variation in measures of blood pressure, adiposity, lipids, 
microalbuminuria, insulin and glucose, whereas age, gender, puberty and physical 
fitness and other environmental covariates accounted for <45% of the total 
phenotypic variance. Thus, the clustering of MS-related traits due to pleiotropy in 
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CHAPTER ONE: INTRODUCTION 
 Anthropological geneticists study human variation within and between 
populations to better understand the causes of variation (Reddy et al. 1997). Since 
anthropometric traits vary within and between populations, studies have been 
conducted to identify the relative contribution of genetic and environmental factors to 
phenotypic variation (Williams-Blangero and Blangero 1989; Relethford et al.1990). 
Anthropological geneticists have applied methods and theories used in the analyses of 
normal variation to study complex diseases and their associated risk factors 
(Majumdar and Rao 1991; Williams-Blangero and Blangero 1993). This dissertation 
is a genetic epidemiological investigation of blood pressure, a complex phenotype, 
and its correlation with metabolic syndrome-related traits using a cohort of Mexican 
American children, in an attempt to understand the web of relationships between 
obesity and hypertension.  
 Obesity, both adulthood and childhood, is a growing global public health 
problem, and childhood obesity is a potential major contributor to the increased 
prevalence of high blood pressure in children (Torrance et al. 2007). According to 
Virdis et al. (2009), it appears that tracking of blood pressure from childhood to 
adulthood is documented and that the occurrence of obesity in younger ages has a 
clinical role. Indeed, as described by Bellisari (2008) in anthropological terms, such 
an increased occurrence of obesity in recent years is the result of interacton between 
human biology and human culture over a long period of evolution. Obesity and 
hypertension have strong genetic determinants, the rapid rise in the prevalence rt s 
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of such disease conditions in recent decades is probably attributable to changing 
environmental factors including socioeconomic and life style factors (e.g., poor 
dietary habits [high calorie intake] and reduced physical activity levels) and 
obesogenic environments such as fast food restaurants and increased television 
viewing time (Harper 2006; Mehta 2007; Gable et al. 2007). In such changing 
environments, it is presumable that “individuals possessing the appropriate 
combination of ancestral energy-conserving genes (gene sequences regulating energy 
levels in the body) at greater risk for overweight and obesity and associated chronic 















Figure 1: The total phenotypic variation (VP) of a given complex trait (e.g., blood pressu ) 
can be partitioned into genetic (VG) and environmental (VE) components. The proportion of 
phenotypic variance that is attributed to additive genetic effects (VG/VP) is called heritability 
(h2). 
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The phenotypes (P) such as blood pressure and obesity are complex in nature, 
which are influenced by genetic (G) and environmental (E) factors and their 
interactions (IGE) (i.e., P = G + E + IGE; Figure 1). The total phenotypic variation of 
a given trait (e.g., blood pressure) [after accounting for the influences of 
environmental covariates (e.g., age and sex), if known] can be partitioned into 
additive genetic and environmental components, using techniques such as the 
variance components analysis (Falconer, 1989; Almasy and Blangero, 1998). The 
covariances or correlations among biological relatives can be used to partition the 
total phenotypic variance of a complex trait into its genetic and environmental 
components. The proportion of phenotypic variance that is attributed to (additive) 
genetic effects is called heritability (h2) (Figure 1).  
 In addition to the determination of trait-specific genes (i.e., genes that 
independently influence variation in a trait such as blood pressure), the genetic basis 
of correlated traits such as blood pressure and obesity can also be explored using 
techniques such as variance components analysis (Falconer 1989; Almasy and 
Blangero 1998; Duggirala et al. 2001). In both theory and practice, the pleiotropic 
effects of genes (see Figure 2) are of particular interest because “the genetic cause of 
correlation is chiefly pleiotropy”, defined as “simply the property of a gene whereby 
it affects two or more characters, so that if the gene is segregating, it causes 














More than one trait 
(SBP and BMI)
 
Figure 2: Illustration of common genetic influences (pleiotropy) on correlated traits such as 
systolic blood pressure and body mass index (BMI) along with environmental effects. 
 
 
According to World Health Organization (WHO), systolic blood pressure 
(maximum pressure exerted by the blood on arterial walls [SBP]) at or above 140 mm 
Hg and diastolic blood pressure (minimum pressure in the blood vessels [DBP]) at or 
above 90 mm Hg are considered as high/elevated blood pressure [EBP] or 
hypertension. For example, a SBP of 120 and a DBP of 80 are considered normal and 
written as 120/80 mm Hg. Blood pressure is a quantitative trait influenced by the 
complex interaction of genetic and environmental factors illustrated in Figure 1. 
Studies indicate that blood pressure variation is attributable to a variety of 
physiological, socio-cultural, and environmental variables (see Figure 2) (Crews and 
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Williams 1999; Puppala 2001). While no clear explanatory model has been proposed 
yet (Crews and Williams 1999; Puppala 2001), it has been suggested that the 
variability in blood pressure within populations is due to several factors such as diet, 
sodium intake, psychosocial stressors, ecological factors, cultural differences, and 
underlying pre-dispositions to etiology associated with ethnicity and biology (Sorof 
and Daniels 2002; Sorof et al. 2004). Other factors include familial aggregation, but 
the contribution of this factor should be interpreted cautiously since shared or 
common familial environmental influences can mimic shared genetic influences 
(Duggirala et al. 2000b). Although environmental factors, both common familial and 
individual specific-random environmental influences, affect blood pressure variation, 
there is ample evidence that blood pressure variation has strong genetic determinants 
(Rice et al. 1989).  
As Puppala et al. (2009) have recently summarized, several studies reported the 
heritability of blood pressure and hypertension to be 15-50%. Heritabilities are 
population specific and can alter during an individual’s life span. It is important to note 
that heritability is a property of not only the variable but also of the population along 
with the environmental circumstances to which the individuals are exposed, and the 
manner in which the phenotype is measured (Falconer and Mackay 1996). In recent 
years, a number of genome-wide linkage scans for blood pressure and hypertension 
identified several chromosomal regions across the genome that contain susceptibility 
genes for blood pressure and hypertension (Puppala et l. 2009). In addition, very 
recently, some studies have used a genome-wide association study (GWAS) approach 
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to localize susceptibility genes for hypertension or blood pressure (e.g., Levy et al. 
2009; Adeyemo et al. 2009). 
As stated above, hypertension and obesity are correlated traits. In fact, the term 
metabolic syndrome (MS) refers to the clustering of various metabolic abnormalities 
such as obesity, insulin resistance and hyperinsulinemia, impaired fasting glucose, 
impaired glucose tolerance [after 2-hr glucose load], dyslipidemia (elevated triglyceride 
and decreased high-density lipoprotein [HDL] cholesterol levels), and hypertension 
(Reaven 1988; DeFronzo 1995; Kraja et al. 2005; Joy and Hegele 2008; Joy et al. 
2008). Several other phenotypes included as metabolic syndrome components are 
microalbuminuria [higher levels of albumin/creatinine ratio in the urine (Leeet al. 
2006)], elevated markers of chronic inflammation, acanthosis nigricans [darkened 
patches on the skin mostly around neck and under the arms or the groin region because 
of abnormally acting insulin receptors (Stuart et al. 1994, 1997; Burke t al. 2000)], 
endothelial dysfunction, polycystic ovary syndrome, and nonalcoholic fatty liver 
disease (Henry 2003; Isomaa 2003; Goldstein 2003; Tracy 2003; Cordain et al. 2003; 
Malnick et al. 2003; Rowley et al. 2003). Metabolic syndrome (MS) is also referred to 
as the Insulin Resistance Syndrome (IRS) or the Dysmetabolic Syndrome or Syndrome 
X (Timar et al. 2000; Groop and Orho-Melander 2001; Isomaa 2003).   
Several diagnostic criteria have been proposed for MS, but the one 
recommended by the National Cholesterol Education Program [NCEP]/Adult Treatment 
Panel III [ATPIII] (NCEP/ATPIII 2001) is widely used. According to this definition, 
metabolic syndrome requires the presence of at least three of five factors: increased 
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waist circumference (>102 cm in men; >88 cm in women), hypertriglyceredemia (≥150 
mg/dl), low HDL cholesterol (<40 mg/dl) in men; <50 mg/dl in women), hypertension 
(≥130/85 mm Hg), and high fasting glucose (≥110 mg/dl). In recent years, several 
analytical tools such as bivariate linkage analysis and factor analysis have been 
employed to localize genes with common genetic influences (pleiotropy) on MS-related 
traits (Duggirala et al. 2001; Arya et al. 2002b).  
Among the several epidemiological diseases (epidemiology is a “science that 
deals with the etiology, distribution, and control of disease in groups of relatives, and 
with inherited causes of diseases in populations” Morton 1978:1), childhood obesity is a 
strong predictor in the development of various chronic conditions in adulthood such as 
type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD) (Tortolero et al. 
1997; Berenson 2002; Srinivasan et al. 2002; Li et al. 2003). Obesity is a condition 
signifying health of a person based on body composition. There are several ways to 
measure obesity, and the frequently used technique is by calculating BMI. It is assumed 
that an individual belongs to a morphological category (obese: BMI ≥95th percentile for 
age and sex or overweight: BMI ≥85th percentile for age and sex among children) if an 
underlying genetically determined risk or liability exceeds certain threshold, such traits are 
also known as threshold traits. Childhood obesity and related risk factors result in a set 
of medical and psychosocial consequences. The medical consequences can be further 
divided into metabolic conditions that include diabetes mellitus, hypertension, 
dyslipidemia, non-alcoholic fatty liver disease; and mechanical conditions including 
obstructive sleep apnea syndrome and orthopedic disorders. The psychological and 
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social consequences such as discrimination and stigmatization of overweight and obese 
children also impact their emotional development (Lee 2009). The increasing 
prevalence of obesity/overweight in children and adolescents is paralleled by increasing 
prevalence rates of its associated disease conditions including T2DM, MS, 
hyperlipidemia and hypertension (Spiotta and Luma 2008). Populations such as 
Mexican Americans are more prone to complex conditions such as obesity (given in 
Figure 3), T2DM and MS compared to general population of the United States (US). 
There is evidence for highest age-adjusted prevalence of MS (~32%) in Mexican 
American adults; and, Mexican American children who are obese or overweight have a 
greater risk of 20% higher prevalence and exhibit similar metabolic syndrome risk 
profiles as in adults (Cook et al. 2003; de Ferranti et al. 2004; Butte et al. 2005). 
Indeed, the important factor associated with metabolic syndrome risk profiles in 
childhood and adolescence is family history of T2DM. Hence, by examining the 
children of the adults whose family-based cohorts have individuals with prediabetes 
(impaired fasting glucose or impaired glucose tolerance or both) and diabetes, w  can 
establish metabolic syndrome profiles as well as understand if there is any disti ct 





Figure 3: The upward trend of increased obesity (BMI ≥30 kg/m2) in the US populations by 
race, ethnicity and gender is illustrated (Smith et al. 2005). 
 
 
The prevalence rates of obesity, hypertension, and T2DM are dramatically 
increasing and affecting both children and adults in US, as well as in other cunt ies, 
and such disease patterns demand immediate attention. An emerging public health issue 
in pediatric populations is the high blood pressure and its correlation with 
overweight/obesity (Torrance et al. 2007), although knowledge of genetic factors that 
underlie such a correlation is limited. Studies reveal that there is a strongassociation of 
body mass index with systolic blood pressure, diastolic blood pressure and also with 
central obesity [waist circumference >102 cm in men and >88 cm in women; also 
measured from waist to hip ratio ≤0.8 in women and ≤1.0 in men] (Venkataramana et 
al. 2001; NCEP/ATPIII 2001; Fezeu et al. 2007; Ostchega et al. 2009; 
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www.centralobesity.com). These associations are assumed to continue in children, and 
it will be interesting to determine the factors, both genetic and environmental, that 
predispose children to these traits. Further, to examine the extent to which they differ 
with adults in the manifestation of a disease phenotype such as hypertension.   
However, it should be noted that the available, but limited, data are not 
consistent regarding the association between blood pressure and other MS risk factor  
in children (Steinberger et al. 2009). Despite advances in examining the genetic factors 
that influence variation in blood pressure and its correlated MS-related traits in dults, 
little is known about the genetic architecture of blood pressure or hypertension and its 
correlation with various MS-related traits in children and adolescents. Especially in 
populations of the US such as Mexican Americans who are at high risk for the 
development of obesity, T2DM, hypertension, and MS. In addition, although the MS 
definition in adults has been shown to be useful both in clinical and research areas, 
there are no set criteria to define MS phenotype in children; and, there have been 
several criteria to define MS in children and adolescents (e.g., Cook et al. 2003; Cruz et 
al. 2004; Zimmet et al. 2007; Steinberger et al. 2009). In consideration of such 
difficulties, as emphasized in a very recent American Heart Association Sc e tific 
Statement (Steinberger t al. 2009:1), there is an immediate need “for early detection 
and preventive measures regarding  cardiometabolic risk factors in children and 
adolescents, with strong focus on obesity, inflammation, insulin resistance, 
dyslipidemia, and hypertension, which emerge as core elements of morbidity”. Such 
early detection of MS risk factors, including blood pressure and obesity, in children and 
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adolescents in large and well-characterized cross-sectional pediatric cohorts is very 
much needed in order to examine such risk factors prospectively, given “the limited 
data  that track individuals from childhood to adulthood” (Steinberger et al. 2009:1). 
Indeed, as the recent American Heart Association Scientific Statement (St inberger et 
al. 2009:10) remarks, the MS risk factors differ significantly by ethnicity; the MS risk 
profiles need to be evaluated using criteria that are specific to ethnicity; and, that the 
genetic and environmental factors that underlie such differential MS risk profiles are 
poorly understood. Also, as stated previously, there is an immediate need for early 
detection of MS risk factors including obesity and blood pressure in the pediatric 
population and for precise understanding of the genetic and environmental influences 
on such traits, both in univariate and multivariate terms.  
Therefore, the major goals of this dissertation are to: (1) examine various 
metabolic syndrome-related traits in Mexican American children such as obesity, 
dyslipidemia, hypertension, impaired fasting glucose, impaired glucose tolerance, 
insulin resistance, and microalbuminuria; (2) determine the genetic influences o  
measures of systolic blood pressure, diastolic blood pressure and other variables (e.g., 
fasting insulin, fasting glucose, microalbuminuria, lipids, and adiposity measures) by 
estimating heritabilities; (3) examine  common genetic influences (i.e., pleiotropy) on 
blood pressure and its related metabolic syndrome-related traits (e.g., obesity) by using 
bivariate genetic analyses; and, (4) investigate potential genetic-by-environment (e.g., 
obesity and lifestyle factors such as physical activity) interaction influences on blood 
pressure. Thus, this dissertation will characterize the pattern of blood pressure variation 
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in Mexican American children and its association with metabolic syndrome-relat d 
phenotypes. Given attention to the differences in components of MS in children by 
ethnicity, which may be attributable to population genetic backgrounds, it is 
hypothesized that the variation in blood pressure and its correlated traits is under strong 
additive genetic influences, and that the additive genetic factors contribute significantly 
to the association between blood pressure and other MS risk factors in Mexican 

















CHAPTER TWO: LITERATURE REVIEW  
Association between obesity, diabetes and metabolic syndrome 
Globally speaking, obesity and T2DM are on the upsurge (nearly epidemic 
magnitude) and are major concerns in developing as well as developed countries. The 
WHO estimates the occurrence of diabetes to rise from 171 million in 2000 to 366 
million in 2030. India is expected to have about 79 million people afflicted with 
diabetes by the year 2030, and will be the first (followed by China and the US) of the 
top 10 countries in the world estimated to have the highest number of people with 
diabetes (Wild et al. 2004). According to the International Obesity Task Force (WHO), 
about 1.1 billion adults are estimated to be overweight and 312 million are considered 
to be obese. These are suggestive of an association between obesity and diabetes 
(Grubbs 2002) and that the link between obesity and T2DM is pronounced (Nadler and 
Attie 2001; Caterson and Gill 2002).  
The prevalence rates of obesity and T2DM differ among populations in the US. 
Mexican Americans and African Americans are particularly at high risk for the 
development of these conditions. For example, in Mexican Americans the incidence of 
T2DM is twofold compared to non-Hispanic Europeans and about ~ 2 million (10%) 
Mexican Americans have T2DM (Stern et al. 1983; Burke et al. 1999). Based on the 
San Antonio Heart Study (SAHS), a secular trend for T2DM was found in Mexican 
Americans in the 1980s (increased from 5.7% in 1979 to 15.7% in 1988) (Burke et al. 
1999). For example, in the SAHS which is a population-based longitudinal study to 
assess T2DM and CVD risk, the results showed that individuals who developed T2DM 
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had a higher body mass index (31.5 [obese] versus 28.1 kg/m2 [overweight]), a higher 
waist/hip ratio (0.898 versus 0.863), higher fasting plasma glucose (95 versus 85 mg/dl) 
and fasting insulin (23 versus 15 µIU/ml) concentrations (Haffner et al. 1995). 
Metabolic syndrome is more common among Mexican Americans (Table 1) (Churilla et 
al. 2007; Razzouk and Muntner 2009), and a population with a higher prevalence of 
metabolic syndrome has a greater risk of T2DM and CVD (Kraja et al.2005; Joy et al. 
2008). In addition, Mexican Americans with T2DM are more likely (i.e., three tims) to 
develop microalbuminuria, a predictor of diabetic nephropathy, than non-Hispanic 
whites (Haffner et al. 1989; Pugh 1996). 
 
 
Table 1: Prevalence rates for metabolic syndrome. Rates for metabolic syndrome are more 





The US is the world leader in the prevalence of obesity and overweight 
(Francischetti and Genelhu 2007). The health care costs for obesity/overweight in the 
US are estimated at ~$100 billion each year (Harper 2006), and will reach $1 trillion 
by the end of 2030 (Wang et al. 2008). In addition to these health problems in adults, 
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childhood overweight/obesity, along with T2DM and metabolic syndrome, have been 
increasing significantly in the US over the past two decades. It is known to be 
correlated with a large number of chronic health conditions and illnesses in adulthood 
(e.g., T2DM, metabolic syndrome, and hypertension). Moreover, about 45 (~ 30%; 
WHO) million of the world’s school-age children are estimated to be obese (Mehta 
2007). In the US, between the years 1980 and 2000, the incidence of overweight in 
children aged 6-11 years more than doubled, while it tripled in adolescents aged 12-
19 years (Harper 2006). According to the 2003-2004 National Health and Nutrition 
Examination Survey (NHANES), the occurrence of overweight in children and 
adolescents aged 2 to 19 years was 17.1% (Ogden et al. 2006).  
Epidemiology of MS in children 
Obese/overweight Mexican American children are at greater risk with 20% 
higher prevalence for the metabolic syndrome (Butte et al. 2005) (estimates vary 
from 5.6% - Cook et al. 2003; and 12.9% - de Ferranti e  al. 2004), and is still higher 
(30%) if there is a family history of T2DM (Cruz et al. 2004). Among Mexican 
American children who are diagnosed with T2DM, 90% are found to be obese and 
75% have two or more abnormal lipid levels (high total cholesterol [TC] and/or high 
low-density lipoprotein [LDL] cholesterol and/or high triglycerides [TG]) (Fortmeier-
Saucier et al. 2008). These findings suggested as the body mass index increased (i.e., 
overweight/obese), the probability of abnormal total cholesterol, triglycerides and 
LDL levels also increased. Previous studies showed a correlation between body mass 
index and lipid levels (Lamon-Fava et al. 1996). In another study (Movassaghi et al. 
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2007), the children of parents with metabolic syndrome had higher serum 
triglycerides, LDL, total cholesterol, fasting blood glucose, and lower HDL, 
indicating a familial aggregation of metabolic syndrome. In Mexican Americans, 
metabolic syndrome rates are high and correlated with age (Smith et al. 2005). MS is 
greater in Mexican Americans, especially women (age effects and sex dimorphism 
are evident), and in children ethnic differences are observed in the expression of MS 
at a young age (Cossrow and Falkner 2004).  
A number of studies have been conducted to verify the factors underlying the 
metabolic syndrome structure (e.g., Arya et al. 2002b). Such studies have found more 
than one factor responsible and interaction of separate biological processes for th  
underlying structure of metabolic syndrome-related multivariate data. Therefor , it is 
likely that the association between obesity (central obesity in particular) and insulin 
resistance (along with hyperinsulinemia) could be the instigating factor in he 
development of metabolic syndrome (Arya et al. 2002b; Caterson and Gill 2002; 
Srinivasan et al. 2002; Fezeu et al. 2007). The underlying biological basis for ethnic 
difference in the predisposition to diabetes could be attributable to insulin resistance 
[as measured by Homeostatic model assessment of insulin resistance [HOMA-IR], an 
indirect measure of insulin resistance] (Huang et al. 2002). To some extent the higher 
rates of obesity-related diabetes in Mexican American population are explained by 
insulin resistance which is a strong correlate of obesity. In addition, the offspring of 
affected parents are more vulnerable and exhibit higher risk to IRS or MS. 
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Using NCEP/ATPIII definition for metabolic syndrome and NHANESIII data 
including 8814 men and women aged ≥20 years, the age adjusted prevalence of 
metabolic syndrome was found to be 24.0% in men and 23.4% in women 
representing a cross-sectional sample of US population (Ford et al. 2002). The 
prevalence showed age-dependence and also differed among ethnic groups. The 
highest prevalence was among Mexican Americans (31.9%) and the lowest among 
non-Hispanic whites (23.8%), African Americans (21.6%) and other ethnic groups 
combined (20.3%) (Ford et al. 2002). Using NCEP/ATPIII definition for metabolic 
syndrome and NHANESIII data including 2430 children aged 12-19 years, and the 
prevalence of metabolic syndrome was found to be 4.2% (6.1% in males and 2.1% in 
females) with the highest in Mexican Americans (5.6%), whites (4.8%), and then 
African Americans (2.0%). Also, 28.7% of overweight adolescents met the condition 
of metabolic syndrome even after stratified by body mass index (Cook et al. 2003). 
Therefore, these rates suggest that ~1million adolescents are affected in th  US, and 
47 million adults are estimated to be affected with metabolic syndrome in the US 
(Cook et al. 2003). In a study based on 126 overweight Hispanic children aged 8-13 
years, the prevalence of metabolic syndrome was found to be 30% (Cruz et al. 2004). 
This study also indicated an association between insulin resistance and the 





Blood pressure and its metabolic correlates  
Hypertension can be classified into two types: essential or primary 
hypertension – chronically elevated blood pressure occurring in the absence of other
predisposing conditions, and secondary hypertension – elevated blood pressure 
mainly due to kidney diseases. This latter condition depends upon regulation of blood 
pressure and which in turn depends on blood transport system and plasma volume. 
Plasma level, in relation to proteins and blood cells, relies on sodium (NA+) and 
potassium (K+) ion concentrations in the blood. This sodium and fluid balance is 
regulated by renin-angiotensin-aldosterone system (RAAS) in the blood. The RAAS
pathway and regulation of blood pressure is illustrated in Figure 4. When the body is 
deficient in fluids, then the pituitary gland releases antidiuretic hormone (ADH) to 
force the kidneys to reduce water filtration. This reduced fluid volume eventually 
leads to a fall in blood pressure that is sensed by receptors on the kidneys and induces 
the release of rennin enzyme. Renin, coupled with angiotensin (which is released by 
liver) forms angiotensin I, which is then converted into angiotensin II catalyzed by 
angiotensin converting enzyme (ACE). This happens during low sodium and 
potassium concentrations. RAAS stimulates absorption of sodium and also 
aldosterone production by the adrenal glands. With the help of these enzymes, RAAS 
influences hemodynamics and vascular tone by maintaining the water and sodium 
balance. Therefore, any changes in the RAAS pathway such as variation in genes 
encoding renin, angiotensinogen, ACE, & angiotensin receptors may lead to essential 
















 Figure 4: The Renin-Angiotensin-Aldosterone System (RAAS).  
 
 
Since the late 1980s, the prevalence of elevated blood pressure has been 
increasing among US children and adolescents. Similar increase is observed for 
general forms of obesity, in particular abdominal obesity. Both obesity and 
hypertension are significantly associated (Cossrow and Falkner 2004). The rise in 
hypertension can be attributed to obesity to some extent (Figure 5) and also clustering 
of risk factors due to metabolic syndrome in children (Din-Dzietham et al.2007). 
Besides, obese children are at higher risk (~3 fold) for hypertension than nonobese 
children (Sorof and Daniels 2002). A high prevalence of overweight is observed in 
Mexican American adolescents. For most ages, males had a higher prevalence of 
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overweight than females. In overweight Mexican American adolescents, hypertension 
establishes early; and, higher systolic blood pressure levels are observed after 
adjusting for other risk factors (Forrest and Leeds 2007). Once hypertension in 
children was considered as secondary and rare, but the hypertension in children seems 
primary and has become common and increasingly associated with obesity and other 
risk factors including a family history and ethnic predisposition to hypertension and 
related diseases. Obesity-related hypertension appears to be a cumulative effect of 
insulin resistance, abnormalities in vascular structure and function and several oth  
associated factors (Sorof and Daniels 2002; Sorof et al.2004). Elevated blood 
pressure at a young age is associated with elevated levels of blood pressure and 









































































































In Mexican school children aged 8 to 10 years, elevated blood pressure is 
associated with overweight in both girls and boys (Genovesi et al. 2008) and also a 
predictor for elevated blood pressure levels (SBP and/or DBP ≥95% for gender, age 
and height) in adulthood (Ostchega et al. 2009; Colin-Ramirez et al. 2009). Based on 
the NHANES cross-sectional data including Mexican Americans, non-Hispanic 
whites and non-Hispanic blacks from three time periods: 1) NHANESIII (1998-1994) 
sample of which 4,673 children were interviewed and examined aged 8-17 years; 2) 
NHANES (1999-2002) sample of which 5,110 children were interviewed and 
examined aged 8-17 years; 3) NHANES (2003-2006) sample of which 4,662 children 
were interviewed and examined aged 8-17 years, obese children and adolescents were 
found to have significantly higher levels of pre-elevated (SBP and/or DBP ≥90 but 
<95% for gender, age and height) and elevated blood pressure values (Ostchega et al. 
2009). There is a significant increase in pre-elevated blood pressure over time in 
Mexican American girls aged 8-12 years, and for non-Hispanic black adolescent girls 
aged 13-17 years. Also, there is a significant association of elevated blood pressure 
over time for adolescent girls aged 13-17 years (Ostchega et al. 2009). The detection 
and control of hypertension is low in Mexican Americans, which is as well an added 
concern. Likewise, the hypertension control differs by ethnicity even after accounting 
for patient characteristics, treatment, and adherence to treatment. The likeli ood of 
uncontrolled hypertension is higher in Mexican Americans, despite medication 




   
Figure 6: BMI for age at or above 95th percentile (left) and 85th percentile (right) by ethnicity 
during 1999-2006 in non-Hispanic whites, non-Hispanic blacks, and Mexican Americans 





Mexican American boys are more likely to have a high body mass index at all 
ages compared to non-Hispanic whites or blacks. Mexican American girls have a 
similar high body mass index to non-Hispanic blacks and a slightly higher risk than 
non-Hispanic whites at most ages represented in Figure 6 (Ogden et al. 2008). High 
body mass index is associated with elevated blood pressure levels in both children 
and adults (Ostchega et al. 2009). Children with BMI ≥95th percentile (obese) have 
higher prevalence of hypertension than children in other percentile categories (Sorof 
and Daniels 2002; refer Figure 7). Several studies showed a significant positive 
association among body mass index, waist circumference and systolic blood pressure, 
but not with diastolic blood pressure. The association among body mass index, waist 
circumference and diastolic blood pressure is unclear may be due to the fact that 
diastolic blood pressure was not analyzed independently from systolic blood pressure 
(Colin-Ramirez et al. 2009). Mexican American children in the mixed hypertensive 
group (both systolic and diastolic blood pressure) have higher weight, body mass 
index and waist circumference values in parallel with higher prevalence of 
overweight and obesity including elevated systolic and diastolic blood pressure levels 









Figure 7: The distribution of hypertension within each BMI percentile category in 




Both body mass index and waist circumference (a measure of abdominal 
obesity) are associated with elevated levels of systolic and diastolic blood pressure 
levels (given in Figure 8). However, waist circumference is a good predictor of blood 
pressure even after correcting for body mass index (Genovesi et al. 2008). Also, 
increase in adiposity over time including increased body mass index, waist 
circumference, skin-fold thickness is associated with increased blood pressure 
(systolic) levels (Jafar 2009). Whereas, total fat intake showed positive association 
with diastolic blood pressure (Colin-Ramirez t al. 2009). These increasing rates of 
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obesity and its co-morbid disease conditions are of major concern to the general 
public, health officials and policy makers because of their implications on Americans’ 
health (AHA 2005). 
 















































































































Multifactorial origins and interactions of MS-related phenotypes 
The complex phenotypes of obesity, T2DM, and hypertension are influenced 
by genetic and environmental factors and their interactions. Aside from genetic 
influences, the rapid rise in the prevalence rates of obesity and T2DM in recent 
decades is attributable to changing environmental factors including socioecnomi  
and life style factors (e.g., poor dietary habits [high calorie intake] and reduced 
physical activity levels) and obesogenic environments such as fast food restaurants 
and increased television viewing time leading to positive energy balance and r sulting 
in an accumulation of body fat (Moore 2000; Harper 2006; Mehta 2007; Gable et al. 
2007). Conversely, increased physical activity and fitness could lead to favorable 
lipid profiles and improvement in insulin sensitivity (Isomaa 2003; CDC 2004). 
Another potential contributing factor to the development of T2DM or insulin 
resistance in children is puberty (ADA 2000; Goran et al. 2003). However, there are 
certain intervention approaches (including lifestyle modifications) that will help a 
child from gaining weight or reach overweight category (Golan 2006; Williamson et 
al. 2008; Swinburn 2009). Not all children respond in a similar way, and there is great 
inter-individual variation to these interventions indicating a possible influence of 
genes and their interactions with lifestyle adjustments. The response variations n 
children for these short-term lifestyle interventions can be attributed to genetic 
influences or some specific variants in disease susceptibility genes and to gene-by-
lifestyle (G x LS) interaction influences (Shiwaku et al. 2003; de Luis et al. 2006; 
Mitchell et al. 2008; Moore et al. 2008).   
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It is well established that obesity and T2DM phenotypes have strong genetic 
determinants (e.g., Duggirala et al. 1999; Comuzzie 2002). The major advances in 
molecular genetic and statistical genetic techniques and the availability of the human 
genome data helped the genome-wide searches to locate disease susceptibility genes. 
Techniques include linkage, association, and admixture mapping (Duggirala et al. 
1999, 2000a, 2001; Comuzzie 2002; Arya et al. 2002a, 2004; Zhu et al. 2005; Tian et 
al. 2006; Grant et al. 2006; Frayling 2007). Importantly, in very recent years, the 
genome-wide association studies have greatly enhanced our understanding of the 
genetic architecture of obesity and T2DM. Variants associated with susceptibility to 
T2DM are the Pro 12 Ala substitution, the Ala allele was common (85%) and 
discovered by testing candidate genes with a relative risk of ~0.8 (Altshuler et al. 
2000); and cysteine protease gene calpain 10 (CAPN10) (Horikawa et al. 2000) 
discovered in Mexican Americans with the help of two intronic SNPs and an indel 
marker the susceptibility of this genotype is associated with diabetes. Th genes of 
these complex traits can be mapped by different approaches. 
 
Methodological approaches to map genes of complex traits  
The two general strategies used to map genes for complex traits are genome-
wide linkage analysis and genome-wide association study approach. Novel integrative 
approaches for the identification of candidate genes in hypertension combine linkage 
and gene expression profiling, and the dissection of physiological phenotypes (Hubner 
et al. 2005). Using the genome-wide linkage analysis, Duggirala et al. (1999) identified 
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a T2DM susceptibility locus on chromosome 10q in Mexican Americans. Also, there is 
evidence for major loci influencing blood pressure and lipoprotein metabolism 
(Krushkal et al. 1999; Duggirala et al. 2000b; Arya et al. 2002b; Rice et al. 2002).  
So far many genome-wide linkage studies, gene candidate analysis, whole 
genome-wide association studies of hypertension and blood pressure-related phenotypes 
have been published (OMIM 145500; Mocci et al. 2009). However, no single genomic 
region has a large effect on hypertension (Mocci et al. 2009), but several genomic 
regions likely to contain essential hypertension-susceptibility loci: 1q, 2p, 2q, 3p, 6q, 
11q, 12q, 13 q, 15q, 18q, and 19p [chromosome number; p - short arm of the 
chromosome; q - long arm of the chromosome] (Rice et al. 2000; Mocci et al. 2009). 
Chang et al. (2007) characterized linkage region 1q23-q32, validated by several other 
studies and supported by blood pressure -related quantitative trait linkage mapping 
studies. The results indicated that 1q harbors multiple essential hypertension-
susceptibility genes that affect blood pressure levels. Variance components li kage 
analysis applied to 1,010 Euro-Americans and 816 Afro-American samples of blood 
pressure found strongest evidence for linkage with a maximum logarithm of odds 
(MLOD) score of 3.2 on chromosome 1q. This finding is also verified by other studies 
including 16 additional STRs genotyped in the region with 2 peaks: 4.3 and 1.8 MLOD. 
Out of the nine positional candidate genes located in close proximity to the MLOD 
peaks, three were potentially related to blood pressure regulation (Xiao et al. 2009): (1) 
ATP1B1 -  a transporter of Na+ and K+ across plasma membrane, regulates Na+ 
absorption, vascular smooth muscle tone regulation, decreased Na, K-ATPase activity 
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precedes development of hypertension in animal models; (2) RGSs (regulator of G-
protein signaling) - mediates vasoconstriction through angiotensin, plays role in 
angiogenesis, may sense hemodynamic change and remodeling of arteries ; (3) SELE 
(encodes E-selectin, an endotheial specific adhesion molecule and marker of endothelial 
function; activated endothelium promotes formation of atheroma, reduces elastic 
properties of arterial wall and alters responsiveness to vasoactive stimuli - part of EH 
Endothelial dysfunction or impaired vasodilation results in elevated plasma levels of 
soluble selectin - common feature of essential hypertension). These findings establish a 
genetic association between blood pressure regulation and response to stress (Henry 
2003; Isomaa 2003; Goldstein 2003; Tracy 2003; Cordain et al.2003; Malnick et al. 
2003; Rowley et al. 2003; Chang et al. 2007; Xiao et al. 2009). 
 A high prevalence (≥70%) of obesity-associated hypertension in French 
Canadian families and a genome-wide scan using multipoint linkage analysis found 
significant loci on chromosome 1 (D1S1597) and 11 (D11S1999) (Pausova et al. 2005). 
Genome-wide scans using factor analysis found a quantitative trait locus on 
chromosome 15q15 for blood pressure in whites (Kraja et al. 2005); quantitative trait 
locus for systolic blood pressure on 20p12 in Pacific Islanders of Kosrae (Shmulewitz 
et al. 2006). In addition, very recently, some studies have used a genome-wide 
association study (GWAS) approach to localize susceptibility genes for hypertension or 
blood pressure (e.g., Levy et al. 2009; Adeyemo et al. 2009). Several novel 
susceptibility genes/variants for T2DM/obesity (e.g., transcription factor 7-like 2 
[TCF7L2] reported in Mexican Americans (Almasy and Blangero 2009; McCarthy et 
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al. 2008; Prokopenko et al. 2008) and fat mass and obesity associated [FTO] genes) 
have been identified in recent years, many with subsequent replication (reviewed by 
Perry and Frayling 2008, Dina 2008).  Montasser et al. (2009) used both genome-wide 
linkage and candidate gene association approaches and detected a major quantitative 
trait locus on chromosome 15q for systolic blood pressure in nonsmokers indicates the 
presence of a locus that influence blood pressure via G x S interactions. Presently, 
several research groups are engaged in positional cloning efforts to identify the disease-
specific functional variants.  
 Despite the above advances in hypertension susceptibility gene discovery 
using data mainly from adult populations, as discussed previously, little is known 
about the factors that underlie the phenotypic expression of components of MS 
including blood pressure as well as the clustering pattern of these components in 
children and adolescents, especially in Mexican Americans who are at high risk for 
the development of T2DM, obesity, hypertension and MS. Therefore, the major 
purpose of this dissertation is to address the issues of blood pressure and its relation 
with other components of MS in children, using data from a well-established cohort 
of Mexican American children. The next chapter describes the genetic 
epidemiological techniques that have been implemented for examining the genetic 





CHAPTER THREE: MATERIALS AND METHODS 
SAFARI Study Design and Sample 
 SAFARI (San Antonio Family Assessment of Metabolic Risk Indicators in 
Youth) project is a multidisciplinary study of genetic and environmental influences 
and their interactions on various metabolic syndrome related traits in children. Th  
study is also designed to explore the extent of similarities between adults nd children 
regarding the precursors of metabolic syndrome, and it seeks to verify whether 
metabolic syndrome in children has distinct etiology. SAFARI children, aged 6-17 
years, are offspring of the adult family members who participated in three ongoing 
large Mexican American family studies in San Antonio, Texas (Figures 9 and 10): the 
San Antonio Family Heart Study (SAFHS, PI: Dr. John Blangero), the San Antonio 
Family Diabetes/Gallbladder Study (SAFDGS, PIs: Dr. Donna M. Lehman and Dr. 
Ravindranath Duggirala), and the Veterans Administration Genetic Epidemiology 
Study (VAGES, PI: Dr. Ralph A. DeFronzo). The SAFARI study is an ongoing 5-
year long project (i.e., 03/01/2005 – 02/28/2010) funded by NICHD/NIH (R01 
HD049051, titled: The Metabolic Syndrome in Mexican American Children, PI: Dr. 
Ravindranath Duggirala). The conduct of SAFARI study has been approved by the 
Institutional Review Board (IRB) at the University of Texas Health Science Center at 
San Antonio (UTHSCSA), San Antonio, Texas. 
 The recruitment of SAFARI children began on September 21, 2005, and 
ended on February 27, 2009. A total of 607 Mexican American children were 
enrolled in SAFARI study. Metabolic syndrome-related data have been collected 
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from each child. After excluding three children that were found to have T2DM at 
SAFARI clinic examinations, this study will examine data from 604 nondiabetic 
children and adolescents. Of the children in SAFARI, almost 80% live in the southern 
and western part of Bexar County. Most of the participants from this study were from 
low-income neighborhoods including Barrio region in downtown, suburban regions 
and transition regions between the two in San Antonio. The number of participants by 
Zip Code in San Antonio, Bexar County, Texas is shown in Figure 10 (i.e., 
distribution of only 544 children is shown). The San Antonio Metropolitan Health 
District identified 10 Zip Codes (78201, 78207, 78210, 78211, 78221, 78223, 78227, 
78228, 78237 and 78242) as poor and high risk areas for ongoing public health 
problems in 2006 (http://www.sanantonio.gov/heath). The average median household 
income of these 10 Zip Codes was $26,824 (http://factfinder.census.gov). These 10 
Zip Code areas represent about 30% of the Bexar County population including 82% 
of Hispanics by ethnicity (http://factfinder.census.gov). About 50% of SAFARI 









Figure 10: Showing the low-income neighborhoods in red and number of SAFARI study 





San Antonio city is the seat of Bexar County (http://www.naco.org) and is the 
second largest city in the state of Texas (Figure 9). Texas is the second largest state in 
the US in both area and population. Over 1/3rd ( 5.5%, most are Mexican Americans) 
of Texas residents are of Hispanic origin (http://factfinder.census.gov). Although a 
majority of Hispanics are recent immigrants from Mexico, some Tejano ancestors 
have multigenerational bonds to 18th century Texas. Mexican Americans are a major 
part of the largest minority group-Hispanics in the US. Accordingly ~44 million 
(14.7%) in the US are Hispanic in origin; in San Antonio, ~61% of the total 
population are Hispanic or Latino in origin. San Antonio has the largest Spanish 
settlement in Texas (http://factfinder.census.gov). According to the 2000 census data, 
42% of the total population in San Antonio comprises of Mexican Americans 
(http://factfinder.census.gov). These Mexican Americans represent an admixed 
population, with admixture proportions approximately 64% from Native Americans 
and 36% from Europeans (Bertoni et al. 2003). 
The SAFARI children and adolescents, aged 6-17 years, represent 368 nuclear 
families as shown in Table 2, and the average number of children per nuclear family 
is ~2 (range 1-5 children). Given that these nuclear families are extensions of the 
original SAFDGS, SAFHS, and VAGES families, the SAFARI children represent th  
bottom generations of these families (refer Figure 11 for an example pedigree). Th  
604 children have generated a total of 2,847 relative pairs including 317 sibling pairs, 
491 first-cousin pairs, 213 first-cousins, once removed, 523 second-cousin pairs, and, 
369 third-cousin pairs and others contributed to the present genetic analyses listed in
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Table 3 along with the relationship coefficients which refers to two times the 
coefficient of kinship of two individuals (Coletta et al. 2009). 
 
Table 2: The distribution of SAFARI nuclear families by study. 
 








Table 3: The distribution of Relative Pairs in SAFARI children. 
 
Relative pair Relationship Coefficient* Number of Pairs 
Siblings 0.50000 317 
Half siblings 0.25000 89 
First cousins 0.12500 491 
First cousins (once removed) 0.06250 213 
Half first cousins 0.06250 59 
Second cousins 0.03125 523 
Second cousins (once removed) 0.01562 370 
Half second cousins 0.01562 170 
Third cousins 0.00781 369 
Third cousins (once removed) 0.00391 104 
Fourth cousins 0.00195 23 
Others 0.25 – 0.00003 119 
Total pairs - 2,847 
  
* The relationship coefficient refers to two times the coefficient of kinship of two individuals.
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Informed consent (assent in some cases) was obtained from each SAFARI 
participant’s parent(s)/participant to be enrolled in the SAFARI study, following the 
guidelines as approved by the IRB, UTHSCSA, San Antonio. A variety of phenotypic 
data have been collected from each child on or two visits/days or a single visit/day, 
using standardized methods given in Table 4. Hence, children had to come twice or 
once with their parents or guardians to complete the clinical examinations and 
questionnaires. All enrollment activities together with the clinical examin tions were 
held at the Texas Diabetic Institute (TDI). All clinical examinations were done under 
the supervision of Drs. Daniel Hale (Medical Director of SAFARI), Jane Lynch and 
Rolando Lozano, who are well-known pediatric endocrinologists. Ms. Sharon 
(SAFARI study coordinator), Dr. Richard Granato and Mr. Roy Resendez were 
involved in the recruitment activities of SAFARI. All of them have excellent rapport 
with both parents and children.  
The required phenotypic data were collected with the help of trained nurses 
(Ms. Margaret Fragoso and Ms. Rhonda Lyons [to minimize the interobserver error])
under the supervision of pediatric endocrinologists (Drs. Hale, Lynch and Lozano). 
The pedigrees were updated with the newly collected information by Ms. Fowler and 
Dr. Granato. Blood samples were collected by the LVN-phlebotomist (LVN – Law 
Enforcement Medical Services) after a 12-hour fast and 2-hours after glucose load for 
assessment of various MS-related phenotypes. About 40ml of blood (including the 4 
oral glucose tolerance test (OGTT) samples of 5 ml each) was drawn from each child 
to carry out various laboratory tests as well as to extract DNA. To assess renal 
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function impairment, morning urine samples were collected. Types of tubes to be 
drawn were determined by the phenotype assay specific protocols. The LVN/Nurse 
Coordinator Ms. Fragoso was responsible for the performance of OGTT on the 
children recruited for this study. The LVN-phlebotomist Ms. Lyons was responsible 
for the processing and distribution of samples. All fasting plasma glucose and OGTT 
analyses, using the glucose-oxidase method on a Beckman Glucose Analyzer 2 
(Beckman, Fullerton), were carried out at the TDI, whereas other blood  samples were 
analyzed at the Population Genetics Phenotyping Laboratory, Department of 
Genetics, SFBR, directed by Dr. John Blangero and co-directed by Dr. Joanne 
Curran. 
MS-related phenotypes to establish the precursors of metabolic syndrome in 
children and adolescents 
Data Collection 
To establish the precursors of metabolic syndrome, various phenotypes were 
measured including obesity, impaired fasting glucose, impaired glucose tolerance, 
insulin resistance, dyslipidemia, hypertension, and microalbuminuria. The 
information on environment-oriented measures including physical activity and 
fitness, pubertal status, dietary intake, and television-viewing time were collected 
using questionnaires. The collected phenotypic data and components of the clinical 




Table 4: Phenotypic data collected over two clinical visits are listed (Courtesy: Duggirala). 
 
 
Visit One  
• Completion of consent process 
• Anthropometry including height, weight, waist circumference, and body composition 
estimated by bioimpedence 
• Blood pressure measurements 
• Fasting blood work for glucose, insulin and lipid profile including total cholesterol, 
HDL cholesterol, LDL cholesterol and triglycerides. OGTT with sample collection at 
six time points (i.e., -15, 0, 30, 60, 90 and 120 minutes after 75-gram glucose load 
including two baseline [i.e., fasting at -15 and 0] and four OGTT for glucose and 
insulin measurements) 
• Urine sample collection (total protein, creatinine and albumin) 
• Resting energy expenditure (REE) measurement  
Visit Two 
• DEXA (fat mass, percent body fat, lean body mass) 
• Harvard Step Test (a measure of physical fitness) 
• Medical history questionnaire 
• Dietary intake history 
• Television-viewing and leisure-time questionnaire 
• Physical activity questionnaire 
  
HDL high-density lipoprotein cholesterol, LDL low-density lipoprotein cholesterol, OGTT 
oral glucose tolerance test, DEXA dual energy X-ray absorptiometry. 
 
 
Anthropometry and body composition 
Using standard procedures, height was measured using wall-mounted height 
rod (Ayrton Stadiometer, model S100) and weight was measured with a digital scale 
(Scale-Tronix, Inc. Wheaton, IL) and the highest value recorded. BMI equals weight 
in kilograms divided by height in meters squared. This continuous variable was 
dichotomized into two traits i.e., overweight (BMI ≥85th percentile for age and sex) 
and obese (BMI ≥95th percentile for age and sex) for understanding the severity and 
variability in adiposity measures. Waist circumference was obtained using a flexible 
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measuring tape. Body composition (fat mass, percent body fat and lean body mass) 
was analyzed with the use of a dual-energy-X-ray absorptiometry (DEXA scan, QDR 
4500W/CE, Hologic, Inc. Bedford, MA). 
Blood pressure measures 
Systolic (SBP) and diastolic (DBP) values were obtained by the trained 
nurses, using a Welch Allyn Spot Vital Signs Monitor. Three readings were recorded 
and the average of the last two considered as a final measure. Again, the blood 
pressure data were dichotomized in the analyses to understand the severity of 
hypertension. Blood pressure ≥90th percentile for sex, age, and height (i.e., SBP or 
DBP ≥90th percentile) is considered as elevated blood pressure [EBP] or hypertension 
(http://www.cdc.gov/nccdphp/dnpao/growthcharts/resources/sas.htm; National High 
Blood Pressure Education Program Working Group on Hypertension Control in 
Children and Adolescents 1996) 
MS-related phenotypes assayed at SFBR Population Genetics Phenotyping 
Laboratory 
The blood chemistry/metabolic variables were measured at the SFBR lab 
facilities. Urine albumin excretion (UAE) is an important phenotype related to renal 
function impairment and diabetic nephropathy, which is measured as urine 
microalbumin to creatinine ratio [mg/gm] (ACR). ACR was measured in the morning 
urine samples using microalbumin/creatinine assay kits either by calorimetric or 
radioimmunoassay method (Siemens, Tarrytown) and analyzed by Bayer DCA 2000 
analyzer at the TDI. Microalbuminuria (MA) is defined as ACR of ≥0.03 and <0.30, 
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while macroalbuminuria is defined as ACR of ≥0.3 (not considered for this study). 
MA is considered for this study as an early maker of renal function impairment. 
Fasting blood work 
Using the following procedures, the serum lipid panel was assayed in the 
Biochemical and Molecular Genetics Laboratory at SFBR. Total cholesterol was 
measured enzymatically using a kit (H/P Reagent from Boehringer Mannheim). HDL 
cholesterol was measured enzymatically using the same reagent as for total 
cholesterol, but after the precipitation of LDL cholesterol and VLDL cholesterol with 
a mixture of dextran sulfate (50,000 MW) and magnesium chloride. Triglycerides 
were measured enzymatically using a kit from Stanbio Laboratories (Stanbio 
Liquicolor Triglycerides). LDL-cholesterol levels were estimated, using the 
Friedewald formula (Friedwald et al. 1972). Serum insulin (RIA, 
MILLIPORE/LINCO) was assayed using the assay type and source mention d in the 
parentheses. 
Impaired fasting glucose (IFG ≥100 and ≤125 mg/dl) and impaired glucose 
tolerance which is 2-hour post-OGTT (IGT ≥140 and ≤199 mg/dl), or both are 
referred to the condition of pre-diabetes, which raises the risk of diabetes. The various 
measures of insulin resistance can be derived from the fasting glucose, post-OGTT, 
and insulin concentrations using methods such as homeostasis model assessment of 
insulin resistance [HOMA-IR or HOMA] (Matthews et al. 1985). HOMA-IR is an 
indirect measure for insulin resistance which is based on fasting insulin and glucose 
(Huang et al. 2002). There is no single proxy measure available that can account for 
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the variability in insulin resistance. Therefore, the use of available proxy measures 
such as fasting glucose and fasting insulin could prove appropriate in the assessment 
of insulin sensitivity (Huang et al. 2002). Here, HOMA-IR is measured as follows: 




The Harvard step test is a simple test of physical fitness, which requires 
minimal equipment (Keen and Sloan 1958; Consoalzio et al. 1963). A modified 
Harvard step test, as described by Trevino et al. (1999, 2004), is used to measure 
physical fitness in SAFARI children. A child’s lower part of the chest was connected 
to a heart rate monitor (Polar Vantage XL, Polar Electric Co.) with a transmitter and 
his/her wrist was connected to a receiver monitor. A baseline heart rate was rcorded. 
Following this, a child was asked to step up and down (both feet) from a stool 30 cm 
high, 42 cm wide, and 38 cm deep at the rate of thirty cycles per minute. This activity 
was continued for 5 minutes or until exhaustion. Immediately after the child either 
completely finished the exercise or stopped the exercise prematurely, heart rat s were 
recorded at 0, 1, and 2 minutes.  The heart rate and duration of test in seconds was 
applied to the following equation to calculate the physical fitness score (PFS):  
PFS = Total time of stepping or duration of exercise [in seconds] x 100)/Sum of three 
heart rates post exercise.   
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Physical and sedentary activity 
Accelerometer-based actical (Mini-Mitter, Bend, OR) activity monitors had 
successfully been used to estimate physical activity/energy expenditur. Prior to the 
clinical examinations, participants were asked with the help of their parents to 
complete 3 days’ physical activity logs, with actical readings. Additionally, ll 
children were asked to fill a questionnaire about physical activity and sedentary 
activity. The physical activity of was evaluated based on time spent per day/week, 
type and perceived exercise level. The sedentary activity was based upon the 
information on amount of television-viewing, video games, and other leisure time 
activities mentioned. The physical activity and sedentary activity for esterday and 
usually were calculated (see Appendix 4) using the Girls health Enrichment Multi-site 
Studies (GEMS) Activity Questionnaire formula described elsewhere (Treuth et al. 
2003, 2004).  
Puberty 
Another important measure considered for this study was puberty which was 
shown to be a significant contributor to insulin resistance (Goran et l. 2003). The 
pubertal status, after physical examination by a physician using the standard Tanner 
stages, was divided into three categories: pre-pubertal, pubertal and post-pubertal. 
During the analyses, while estimating heritabilities with significant covariates, two 
dummy variables were created to account for the pre-, pubertal and post-pubertal 




Univariate genetic analysis 
 A well-established model of multifactorial inheritance that has been used to 
partition total phenotypic variation of a given trait (e.g., blood pressure) into genetic 
and environmental components (i.e., univariate genetic analysis) is the variance 
components analysis (Falconer and MacKay 1996; Almasy and Blangero, 1998).    
Heritability (h2) is defined as the total phenotypic variance in a trait (e.g., blood 
pressure) that is attributed to genetic factors (Falconer and Mackay 1996). There are 
two forms of heritabilities: broad- and narrow-sense heritabilities. The heritability in 
broad-sense is defined as the proportion of the total phenotypic variation (VP) that is  
determined by genetic components (VG), which can be further divided into additive 
(VA) and dominance (VD) components. 
 
The narrow-sense heritability is defined as the total phenotypic variance (VP) 
that is attributed to additive genetic factors (VA). This heritability measure is used for 
the present study as it considers the degree of resemblance between relative pairs and 




h2 = VG/VP = (VA+VD)/VP
       (1) 
h2 = VA/VP        (2) 
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Variance components analysis for quantitative or continuous phenotypes 
According to the standard quantitative genetic theory, covariances or 
correlations among biological relatives can be used to partition the total phenotypic 
variance of a continuously distributed trait (e.g., blood pressure) into its genetic a d 
environmental components (Duggirala 1995; Falconer and Mackay 1996). The total 
phenotypic variance of a given trait (e.g., blood pressure) can be partitioned into 
genetic and nongenetic components using a variance components analytical approach. 
In a simple model, variances or covariances between relatives as a function of the 
genetic relationships can be specified, and the proportion of phenotypic variance that 
is attributed to (additive) genetic effects (i.e., heritability: h2) can be estimated from 
the components of variance (Hopper and Mathews 1982; Falconer 1989). For such a 
simple model, the covariance matrix for a family (Ω) is given by:  
 
Where Φ is the kinship matrix; σ 2g is the genetic variance due to additive 
genetic effects; I is the identity matrix; and σ 2e is the variance due to individual-
specific environmental effects. To better evaluate the genetic basis of a given 
phenotype, using maximum likelihood techniques, heritability was estimated along 
with the phenotypic mean and standard deviation and covariates (sex and age effects, 
puberty and physical fitness), simultaneously (Duggirala et l. 2001).  
 A likelihood ratio test is used to test whether the heritability of a given 
phenotype (h2 = 0) was zero. This is conducted by setting the likelihood of a restricted 
Ω = 2Φσ2g + Iσ
2
e       (3) 
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model in which the parameter h2 was constrained to a value of zero and compared to 
that of a general model in which the same parameter was estimated. A test statistic
can be yielded by doubling the difference in log-likelihoods of these models, which is 
asymptotically distributed, as a ½:½ mixture of a χ21 distribution and a point mass at 0 
(Self and Liang 1987; Duggirala et al. 2001). Using likelihood ratio tests, the null 
hypotheses of no influence of a given covariate (βCOVARIATE = 0) were tested. A given 
parameter is compared in each of these tests and involves 1 degree of freedom. A 
statistically significant test, if p <0.05 would be considered evidence of a significant, 
non-zero estimate for a given parameter (Duggirala et al. 2001). The analyses of 
procedures are incorporated in the program SOLAR [Sequential Oligogenic Linkage 
Analysis Routines] (Almasy and Blangero 1998). 
Variance components analysis for qualitative or dichotomous phenotypes 
Although the above variance components method is appropriate to quantitative 
traits, it can be extended to the dichotomous or discrete (disease = yes or no) traits such 
as hypertension or metabolic syndrome or its components as defined by the 
NCEP/ATPIII criteria (Duggirala et al. 1997; 1999). It is assumed that an individual 
belongs to a specific disease category if the liability or underlying genetically 
determined risk exceeds a certain threshold, T, on a normally distributed liability curve 
(Puppala et al. 2006). The liability is assumed to have an underlying multivariate normal 
distribution with equal unit variances both in the general population and in relatives of 
affected individuals. The correlation in liability between pairs of individuals will be 
estimated using the affected status of unrelated individuals and various categories of 
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relatives (Duggirala et al. 1997; 1999; Puppala et al. 2006). For a simple model, the 
correlation (ρ) in liability between individuals i and j is given by:  
  
Where Φij gives the kinship coefficient for individuals i and j; h
2 is the 
heritability due to additive genetic effects; Iij gives the coefficient for the random 
environmental effects for individuals i and j; and e2 = 1 - h2 (Lin et al. 2005; Puppala 
et al. 2006). Since calculation of the likelihood for this multifactorial model requires 
high dimensional integration, the Mendell/Elston algorithm (1974) will be used for 
evaluation, approximately. Similar to the quantitative traits, the variance components 
and covariate effects for discrete traits were estimated in likelihood terms, and 
hypothesis were tested using likelihood ratio tests (Lin et al. 2005; Puppala et al. 
2006). The computer program SOLAR is implemented for this variance components 
procedure for discrete traits (Almasy and Blangero 1998). 
Multivariate variance components analysis: Determination of common genetic 
influences (i.e., pleiotropy) on correlated phenotypes 
By extending the univariate variance component model to the multivariate 
situation, the bivariate variance components analysis can be used to partition 
phenotypic correlation (ρp) between a pair of quantitative phenotypes (e.g., SBP and 
HDL cholesterol) into additive genetic (ρg) and environmental (ρe) components using 
information on genetic relationships between relatives and with the maximum 
likelihood technique (Hopper and Mathews 1982, Lange and Boehnke 1983, 
ρij = 2Φij h
2 + Iij e
2       (4)  
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Williams-Blangero and Blangero 1993). An extension of this approach can be 
employed to conduct the bivariate analysis of quantitative and dichotomous (e.g., 
SBP and overweight) or two dichotomous traits (e.g., hypertension and 
microalbuminuria) (Williams et al. 1999a, 1999b; Burke t al. 2000). The nature of 
the phenotypic correlation (ρP) between a pair of traits is given by:                        
 
Where ρP is the phenotypic correlation; ρG is the additive genetic correlation; 
ρE is the random environmental correlation; h
2
1 is the heritability of trait 1; h
2
2 is the 




2 is equal to 1-h
2
2 . The significance of the 
phenotypic, additive genetic, and random environmental correlations were 
determined, respectively by using likelihood ratio tests (Burke et al.2000; Lopez-
Leon et al. 2009). For example, to determine whether ρG between two traits is 
significantly different from zero or not, the log-likelihood of a model in which the 
parameter ρG was constrained to equal zero was compared with a model where the 
same parameter was estimated. A test statistic can be yielded by doubling the 
difference in log-likelihoods of these models, which is asymptotically distributed as a 
Χ2 statistic (Burke et al. 2000; Lopez-Leon et al. 2009). The difference in the number 
of parameters estimated in the two competing models equals the degrees of fredom 
(Burke et al. 2000). The bivariate genetic analysis can incorporate covariate effects 
                     ____              ____ 








2 ρE      (5) 
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(e.g., age and sex). The procedures of bivariate analysis are incorporated in the 
computer program SOLAR (Almasy and Blangero1998).   
Selection of Covariates 
 In our variance component analysis, a number of covariates (i.e., intermediate 
physiological phenotypes or environmental factors) of a given disease phenotype 
(e.g., SBP or DBP) were included in the model, and they might influence the 
proportion of the total phenotypic variance associated with polygenic effects. The 
covariate screening options in the program SOLAR is used to identify important 
covariates of the MS or its related disease conditions. The covariates included in the 
initial genetic analyses were sex, age, age2, age*sex, age2*sex [interaction], puberty, 
physical activity and fitness effects. However, only significant covariates were 
considered for the final models. For a given analysis, to minimize the problem of non-
normality, outliers, defined as ± 4 standard deviations from the mean were excluded. 
For the variables such as fasting insulin, HOMA-IR, triglycerides, BMI and body fat - 









CHAPTER FOUR: RESULTS 
Descriptive characteristics of the study sample 
Demographic, hemodynamic, and renal function-related variables 
The demographic, hemodynamic, and renal function characteristics of the 
total study population and boys and girls separately are presented in Table 5. This
table describes the following variables used in this study: demographic (age and 
gender), hemodynamic (systolic blood pressure, diastolic blood pressure, elevated 
blood pressure [higher systolic or diastolic blood pressure or both based on 90th
percentile for age, sex, and height]), and renal-function related (microalbuminuria) 
traits. The mean age of the SAFARI participants was 11.6 ± 3.4 years, and 50% of the 
participants were girls. The mean values (mm Hg) for systolic and diastolic bl od 
pressure were 104.2 ± 9.8 and 63.1 ± 7.0, respectively. The systolic blood pressure 
(boys - 105.7 ± 10.1, girls - 102.7 ± 9.2) was significantly different between sexes (p 
= 0.000) and diastolic blood pressure (boys - 62.9 ± 7.0, girls - 63.4 ± 7.0) values 
were not significantly different between boys and girls (see Figure 12).  
High blood pressure 
Of the total participants, 10.3% of children had SBP greater than or equal to 
90th percentile and 6.8% of them had higher DBP, whereas, the prevalence of 
elevated BP (EBP) or hypertension was 12.6% in the total study population (i.e., 
either SBP or DBP greater than or equal to 90th percentile). However, the 
dichotomized blood pressure (normal vs. hypertensive) variables such as SBP≥90 and 
EBP≥90 were higher in boys (11.6% and 13.6%) than girls (8.9% and 11.6%). In 
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contrast, DBP≥90 was slightly higher in girls (7.3%) than boys (6.3%) (see Figure 
15).  
Microalbuminuria 
 ACR is an important early marker for kidney disease and generalized 
endothelial dysfunction. These conditions are reflected by the amount of urinary 
albumin/creatinine excretion which is associated with several risk factors of the 
metabolic syndrome (Lee et al. 2006). The prevalence of microalbuminuria was 9.1% 
overall, and the prevalence of microalbuminuria was extremely high in girls (14.1%) 
which was significantly higher (p =0.000) than boys (only 4.0%) (see Figure 15). 
This finding is consistent with other studies that found girls to be more likely to have 
higher microalbuminuria than boys (Davies et al. 1984; Nguyen et al. 2008). As 
reported by Davies et al. (1984), urinary albumin excretion in girls was significantly 
higher daytime but not nighttime, compared with boys, in turn suggesting that girls 
have more orthostatic albuminuria [the condition where traces of albumin in urine are 









Table 5: Descriptive characteristics of demographic, hemodynamic, and renal function-




          Girls Boys Total 
Variable Sample 
size 








Mean ± SD 
or % 
Age (years) 302 11.6 ± 3.5 302 11.5 ± 3.4 604 11.6 ± 3.4 
Sex 302 - 302 - 604 50% 
SBP (mm Hg)* 298 102.7 ± 9.2 298 105.7 ±10.1 596 104.2 ± 9.8 
DBP (mm Hg) 301 63.4 ± 7.0 299 62.9 ± 7.0 600 63.1 ± 7.0 
SBP≥90 302 8.9  302 11.6  604 10.3 
DBP≥90 302 7.3  302 6.3  604 6.8 
EBP≥90 302 11.6  302 13.6  604 12.6 
MA* 297 14.1 300 4.0 597 9.1 
  
 
*p <0.005 for gender, SBP systolic blood pressure, DBP diastolic blood pressure, SBP≥90 
SBP ≥90th percentile, DBP≥90 DBP ≥90th percentile, EBP≥90 SBP or DBP ≥90th percentile, 

























Figure 12: Systolic (boys - 105.7, girls - 102.7) and diastolic blood pressure (boys - 62.9, 




Lipid, insulin and glucose metabolism related variables 
 The descriptive characteristics of lipid, insulin and glucose metabolism related 
variables of the total study population are presented in Table 6. This table describes 
the variables used: total cholesterol, triglycerides, high-density lipoprotein (HDL) 
cholesterol, low-density lipoprotein (LDL) cholesterol, fasting glucose, 2-hr glucose, 
fasting insulin, and homeostasis model assessment of insulin resistance (HOMA-IR). 
The lipid profile including total cholesterol (mg/dl), triglycerides (mg/dl), HDL 
(mg/dl) and LDL (mg/dl) cholesterol values in boys were 149.2 ± 28.2, 75.6 ± 43.6, 
45.9 ± 11.1, 87.8 ± 24.0, and in girls were 146.0 ± 24.3, 77.5 ± 38.0, 44.3 ± 9.9, 85.6 
± 20.8, respectively. Overall, the lipid measurements were higher (except for 
triglycerides) in boys (see Figure 13). The mean fasting glucose (mg/dl), 2-hour 
glucose (i.e., oral glucose tolerance test, OGTT, mg/dl) and fasting insulin (µIU/ml) 
measures for the total sample were 89.8 ± 7.5, 115.6 ± 21.1 and 9.0 ± 9.0, 
respectively. The means were significantly different for fasting glucose 
between boys and girls (p =0.002), and both of the glucose measurements were 
somewhat higher in boys (90.7 ± 7.6 and 116.2 ± 21.2) than girls (88.8 ± 7.2 and 
115.1 ± 21.0), respectively. The mean HOMA-IR value in this population was 1.9 ± 
1.6.  The fasting insulin and HOMA-IR were higher in girls (9.7 ± 9.4 and 2.0 ± 1 7) 
than boys (8.4 ± 8.4 and 1.8 ± 1.4). These results indicate that the glucose measures 





 The dyslipidemia pattern, characteristic to T2DM, is low HDL cholesterol 
levels and high triglyceride levels (i.e., hypertriglyceridemia). The prevalence of low 
HDL (i.e., HDL equal to or lower than 10th percentile for age and sex, Butte et al. 
2005) in the total sample was 23.8% (boys – 21.9% and girls – 25.7%; see Figure 15). 
The prevalence of hypertriglyceridemia (i.e., triglycerides greate  than 90th percentile 
for age, Butte et al. 2005) in the total sample was found to be 5.9% (boys – 5.7% and 
girls – 6.1%; see Figure 15).  Thus, low HDL appears to be a major MS risk factor in 
SAFARI children. 
Prediabetes 
 Impaired fasting glucose (IFG ≥100 and ≤125 mg/dl) and impaired glucose 
tolerance [i.e., 2 hour glucose] (IGT ≥140 and ≤199 mg/dl), or both are referred to the 
condition as pre-diabetes, which is a strong predictor of T2DM. The prevalence rates 
of IFG, IGT, and prediabetes in the total sample were 7.3%, 12.3%, and 14.7%, 
respectively (see Figure 15). The patterns of IFG (boys - 8%, girls - 7%) and IGT 
(boys - 13%, girls - 12%) appear to be similar in boys and girls. Overall, the 







Table 6: Descriptive characteristics of lipid, insulin and glucose metabolism related variables 




          Girls Boys Total 
Variable Sample 
size 








Mean ± SD 
or % 
TC (mg/dl) 279 146.0 ± 24.3 282 149.2 ± 28.2 561 147.6 ± 26.4 
TG (mg/dl) 280 77.5 ± 38.0 283 75.6 ± 43.6 563 76.5 ± 40.9 
HDL (mg/dl) 279 44.3 ± 9.9 282 45.9 ± 11.1 561 45.1 ± 10.6 
LDL (mg/dl) 278 85.6 ± 20.8 282 87.8 ± 24.0 560 86.8 ± 22.5 
FG (mg/dl)* 282 88.8 ± 7.2 286 90.8 ± 7.7 568 89.8 ± 7.5 
2-hr G (mg/dl) 194 115.1 ± 21.0 189 116.2 ± 21.2 383 115.6 ± 21.1 
FI (µIU/ml) 281 9.7 ± 9.4 286 8.4 ± 8.4 567 9.0 ±  9.0 
HOMA-IR 276 2.0 ± 1.7 285 1.8 ± 1.4 561 1.9 ± 1.6 
  
 
*p <0.005 for gender, TC total cholesterol, TG triglycerides, HDL high-density lipoprotein 
cholesterol, LDL low-density lipoprotein cholesterol, FG fasting glucose, 2-hr G two hour 





















Figure 13: Lipid profiles in Mexican American children by sex (boys vs. girls were TC total 
cholesterol: 149.2 vs. 146.0, TG triglycerides: 75.6 vs. 77.5, HDL high-density lipoprotein 
cholesterol: 45.9 vs. 44.3, and LDL low-density lipoprotein cholesterol: 87.8 vs. 85.6). 
 
 58
Adiposity and body composition measures 
 The adiposity and body composition measures are described in Table 7. The 
variables include: BMI, waist circumference, overweight, obesity, total fa  mass, lean 
body mass, and percent body fat. The average BMI was 22.8 ± 6.6. As given in Table 
7, about 52.2% of the children were overweight (BMI ≥85th percentile for age and 
sex) and 33.1% were obese (BMI ≥95th percentile for age and sex). The average BMI 
was similar for both boys and girls (22.8).  However, when the BMI was 
dichotomized into overweight and obese categories, then 54.6% of boys tend to be at 
risk for overweight and 36.1% were classified as obese compared to 50.0% and 
30.1% of girls indicating higher overweight and obese rates in boys. However, the 
prevalence of abdominal obesity (i.e. waist circumference >90th percentile for age and 
sex; Butte et al. 2005), was found to be 14.0%, and it was slightly higher in girls 
(14.8%) compared to boys (13.6%) (see Figure 15). The mean total fat mass (kg), 
lean body mass (kg), and percent body fat measures for the total study sample were 
16.2 ± 11.2, 33.5 ± 13.6, 30.2 ± 10.0, respectively. The waist circumference (mm) 
and lean body mass averages were higher in boys (770.0 ± 188.9 and 35.9 ± 15.5 to 
764.3 ± 174.3 and 31.0 ± 10.9), whereas the total fat mass and percent body fat were 
higher in girls (17.0 ± 10.9 and 32.7 ± 8.7 to 15.4 ± 11.5 and 27.8 ± 10.5).  
 The adiposity measures were higher for boys in all categories except for 
percent body fat and total fat mass given graphically in Figure 14, which is a general 
tendency observed in females. Whereas, the lean body mass and percent body fat 
measures are significantly different with p =0.000 for the gender. The sex hormones 
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influence the body composition differently in males and females. Males due to 
testosterone tend to have more bone mineral and lean muscle mass in the upper body, 
whereas females due to estrogen exhibit a greater percentage of body fat (Mosher and 
Crawford 2009).  




          Girls Boys Total 
Variable Sample 
size 








Mean ± SD  
or % 
BMI (kg/m 2) 302 22.8 ± 6.6 302 22.8 ± 6.5 604 22.8 ± 6.6 
WC (mm) 296 764.3 ± 174.3 299 770.0 ± 188.9 595 767.2 ± 181.6 
OW  302 50.0 302 54.6 604 52.2 
OS  302 30.1 302 36.1 604 33.1 
TF (kg) 267 17.0 ± 10.9 277 15.4 ± 11.5  544 16.2 ± 11.2  
TLF (kg)* 267 31.0 ± 10.9 277 35.9 ± 15.5 544 33.5 ± 13.6  
TPF * 267 32.7 ± 8.7 277 27.8 ± 10.5 544 30.2 ± 10.0 
  
*p <0.005 for gender, BMI body mass index, WC waist circumference, OW overweight, OS 
obese, TF total fat mass, TLF lean body mass, TPF percent body fat. 
 
 











Figure 14: Adiposity measures in Mexican American children by sex (girls vs. boys were 
waist circumference: 76.43 vs. 77.0, percent body fat: 32.7 vs. 27.8, lean body mass: 31.0 v. 
35.9, fat mass: 17.0 vs. 15.4, obese (%): 30.1 vs. 36.1, overweight (%): 50.0 vs. 54.6, BMI: 
22.8 each). 
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Physical activity and physical fitness 
 The physical activity and physical fitness scores are described in Table 8. The  
variables include: physical activity yesterday (METS_y), physical a tivity usually 
(METS_u), sedentary activity yesterday (SED_y), sedentary activity usually 
 (SED_u), and physical fitness score (PFS). The physical activity and sedentary 
activity overall was higher than the activities from the day before data collection (2.0 
± 1.2 vs. 1.5 ± 1.2 and 0.7 ± 0.3 vs. 0.5 ± 0.3). The physical activity (including 
activity overall and from the day before data collection) and physical fitness score 
measures differ significantly for gender (p =0.000), but not the sedentary activity. The 
physical fitness score was 58.1 ± 31.5 representing the total study sample. The boys 
physical activity usually (2.2 ± 1.2 to 1.8 ± 1.2; [p =0.000]) and physical fitness 
scores (67.0 ± 32.5 to 49.3 ± 27.8; [p =0.000]) were significantly higher than girls 
indicating that boys are more likely to be physically active than girls. 
 
Table 8: Descriptive characteristics of physical activity and physical fitness scores of 
SAFARI participants. 
 
          Girls Boys Total 
Variable Sample 
size 








Mean ± SD 
or % 
METS_y* 294 1.2 ± 1.1 298 1.7 ± 1.2 592 1.5 ± 1.2 
METS_u* 295 1.8 ± 1.2 296 2.2 ± 1.2 591 2.0 ± 1.2 
SEDS_y 295 0.5 ± 0.3 296 0.5 ± 0.3 591 0.5 ± 0.3 
SEDS_u 292 0.7 ± 0.3 293 0.7 ± 0.3 585 0.7 ± 0.3 
PFS* 213 49.3 ± 27.8 211 67.0 ± 32.5 424 58.1 ± 31.5 
  
 
*p <0.005 for gender, METS_y physical activity yesterday, METS_u physical activity usually, 




Summary of the components of metabolic syndrome 
The prevalence of the components of the metabolic syndrome in Mexican  
American children are presented in Figure 15. In boys, higher prevalence of elevated 
blood pressure (13.6% to 11.6% in girls) and prediabetes (16% to 14% in girls) were 
observed. However, the occurrence of abdominal obesity was slightly higher in girls 
(14.8%) than boys (13.6%). Likewise, both low HDL and hypertriglycerdemia 
prevalence rates were higher in girls (25.7% and 6.1%) compared to boys (21.9% and 
5.7%). In girls (14.1%), the higher prevalence of microalbuminuria (MA) was 
observed. In summary, these data reveal a high risk of overweight and obesity in 
these children – greater than 52% and 33% (Table 7), respectively. The increased 
occurrence of prediabetes and dyslipidemia in this cohort indicates a predisposition t  
diabetes-related complications. The high occurrence of microalbuminuria in these 
children suggests that, even at very young ages, these children may alread be 


































































Figure 15: The prevalence of MS related components in Mexican American children. Th  
bars represent boys at the bottom, girls in the middle, and total population at he top. SBP≥90 
SBP ≥90th percentile, DBP≥90 DBP ≥90th percentile, EBP≥90 SBP or DBP ≥90th percentile, 
IFG impaired fasting glucose, IGT impaired glucose tolerance, Prediabetes prediabetes, Low-
HDL low high-density lipoprotein cholesterol, Hyper-TG hypertriglyceridemia, Abd-Obesity 
abdominal obesity, and MA microalbuminuria.  
 
 
Univariate genetic analyses  
The majority of variables reported in Table 9 have exhibited significant 
moderate-to-high heritabilities listed in Tables 5 to 8. This table provides the 
heritability estimates along with proportion of variance explained by significa t 
covariates included the final models. After accounting for the variation due to ag , 
age2, sex, age*sex, age2*sex, puberty, physical activity and fitness, the heritability 
estimates range from 25% (2-hr glucose) to 100% for DBP≥90 and percent body fat. 
The high heritabilities observed for various traits should be interpreted with caution 
since the analytical design used in this study did not allow for shared environmental 
effects. Thus, given the nature of this pediatric population (i.e., 6-17 years old 
children living with their parents), the estimates of heritability are potentially inflated 
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due to shared familial-environmental influences. However, such estimates are 
reflective of increased familial aggregation of these traits.  
The blood pressure variables including both continuous (SBP and DBP - 70%) 
and dichotomous (SBP≥90 - 97% and BP≥90 - 76%) were highly heritable in this 
SAFARI cohort. Likewise, high heritabilities were observed for various traits, 
especially the overweight and obesity measures (84% for both) followed by total fa  
mass (79%), triglycerides (78%), HDL (69%), BMI and waist circumference (each 
66%), respectively. Subsequently, high-to-moderate heritabilities were observed for 
HOMA-IR (55%), total cholesterol (54%), LDL and microalbuminuria (each 49%), 
fasting insulin (45%) and fasting glucose (27%). However, heritability estimates of 

























Table 9: Heritabilities of MS-related phenotypes with proportion of variance and sig ificant 
covariates in the model.  
 
 





SBP (mm Hg) 0.70 ± 0.11 (<0.0001) 18.2% Age, Sex, Age*Sex 
DBP (mm Hg) 0.70 ± 0.15 (<0.0001) 8.9% Age, Puberty, PFS 
SBP≥90 0.97 ± 0.27 (0.0005) -  
DBP≥90 1.00 b                (0.0008) - PFS 
EBP≥90 0.76 ± 0.37 (0.0216) - PFS 
MA 0.49 ± 0.11 (0.0233) 6% Sex 
    
TC (mg/dl) 0.54 ± 0.16 (0.0004) 6.3% Age, Puberty, PFS 
TG (mg/dl) a 0.78 ± 0.14 (<0.0001) 5.9% Age*Sex, Age2 , PFS 
HDL (mg/dl) 0.69 ± 0.15 (<0.0001) 6.8% Age*Sex, Puberty, PFS 
LDL (mg/dl) 0.49 ± 0.17 (0.0015) 5.8% Age, Age*Sex, Puberty, PFS  
FG (mg/dl) 0.27 ± 0.12 (0.0080) 0.6% Puberty 
2-hr G (mg/dl) 0.25 ± 0.15 (0.0391) 0.4% Age2 
FI (µIU/ml)  a 0.45 ± 0.16 (0.0012) 15.7% Age2, Puberty 
HOMA-IR  a  0.55 ± 0.17 (0.0003) 14.9% Puberty, PFS 
    
BMI  (kg/m2)a 0.66 ± 0.14 (<0.0001) 37.4% Age, Sex, Age2 , Puberty, PFS 
WC (mm) 0.66 ± 0.14 (<0.0001) 39.0% Age, Sex, Age*Sex, Age2, Puberty, PFS 
OW 0.84 ± 0.23 (0.0002) 7.0% Sex, Age2, Puberty, PFS 
OS 0.84 ± 0.23 (0.0009) 10.0% Sex, Age*Sex, Age2, Puberty, PFS 
TF (kg) a 0.79 ± 0.15 (<0.0001) 44.9% Age, Age2, Puberty, PFS 
TLF (kg)  a 0.57 ± 0.16 (0.0003) -  
TPF 1.00b          (<0.0001) 19.5% Age*Sex, Age2, PFS 
  
 
a Log transformed, b Went to the boundary, p <0.05 are considered significant and in bold, SE 
standard error, SBP systolic blood pressure, DBP diastolic blood pressure, SBP ≥90 SBP ≥ 
90th percentile, DBP≥90 DBP ≥ 90th percentile, EBP≥90 SBP or DBP ≥ 90th percentile, PFS 
physical fitness score, MA microalbuminaria, TC total cholesterol, TG triglycerides, HDL 
high-density lipoprotein cholesterol, LDL low-density lipoprotein cholesterol, FG fasting 
glucose, 2-hr G two hour glucose, FI fasting insulin, HOMA-IR homeostasis model 
assessment for insulin resistance, BMI body mass index, WC waist circumference, OW 







When the covariates were concerned (excluding the questionnaire-based 
physical activity measures which showed no effect on any traits), age, age2, pub rty 
and physical fitness score reveal significant effects on total fat mass explaining about 
45% variation in the phenotype. For waist circumference, 39% of variation in the trait 
was significantly influenced by age, sex, age*sex, age2, puberty, fitness score. 
Similarly for BMI, 37.4% of variation is explained by all of these covariates except 
age*sex. For overweight and obese, about 7 -10% of phenotypic variation was 
explained by these environmental covariates. With HOMA-IR and insulin measures, 
puberty and fitness score had significant effects with proportion of variance r g d 
from 14.9 - 16.7%. For glucose measures including both fasting and 2-hr OGTT, age2 
and puberty were found to be significant covariates. In case of lipids, ~6 - 7% of 
variations in the traits were explained significantly by age, puberty, fitness score for 
total cholesterol, all of these covariates along with age*sex for LDL, age*sex, 
puberty, fitness score for HDL, and for triglycerides – age2 instead of puberty. For 
microalbuminuria, only sex effects (6%) were found to be a significant covariate. For 
the blood pressure variables, age, sex and age*sex had significant effects (18.2%)on 
systolic blood pressure trait. But for diastolic blood pressure, it was age, puberty and 






Multivariate genetic analyses  
Systolic blood pressure (SBP) as a quantitative trait and other MS-related traits 
 The phenotypic, additive genetic, and random environmental correlations 
between SBP (as a continuous variable) and metabolic syndrome-related traits are 
presented in Table 10. The phenotypic correlations were statistically significant (p 
<0.05) for most of the variables considered, with the exception of microalbuminuria, 
HDL and LDL cholesterol, ranged from 0.13 to 0.31. While, the total cholesterol 
showed borderline significant phenotypic correlation (0.09, p =0.0880). The genetic 
correlations were significant for triglycerides, fasting insulin, HOMA-IR, BMI, waist 
circumference, overweight, and lean body mass and ranged from 0.32 to 0.53. For the 
traits such as obese and total fat mass there was suggestive evidence for significant 
genetic correlation. There were no significant environmental correlations for SBP 
with other traits, and in general, these correlations were substantially lower than the 
genetic correlations. Therefore, the phenotypic correlations of SBP with metabolic 
syndrome-related traits are mostly influenced by genetic factors but not the 
environmental factors. Thus, pleiotropy (i.e., common genetic influences on 
correlated traits) appears to underlie the observed clustering of SBP with other 




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































b   
   
   









Diastolic blood pressure (DBP) as a quantitative trait and other MS-related traits 
The phenotypic, additive genetic, and random environmental correlations 
between DBP (as a continuous variable) and other metabolic syndrome risk factors
are presented in Table 11. The phenotypic correlations were statistically significant (p 
<0.05) for most of the variables considered, with the exception of microalbuminuria, 
total cholesterol, HDL, LDL, and 2-hr glucose, ranged from 0.12 to 0.22. While, the 
fasting glucose showed borderline significant phenotypic correlation (0.09, p 
=0.0939). The genetic correlations were significant for triglycerides, fasting insulin, 
HOMA-IR, BMI, overweight, obese, total fat mass and percent body fat and ranged 
from 0.32 to 0.61. For the traits such as HDL and waist circumference there was 
suggestive evidence for borderline significant genetic correlations -0.31 and 0.32, 
respectively. The environmental correlation was statistically significa t only for 
triglycerides (-0.77) and suggestive evidence was observed for obese measure. Since 
that the genetic correlation between DBP and triglycerides was strong and positive,  
the estimated large standard error for the negative environmental correlatin between 
the same traits downplays its significance. Overall, as in the case of SBP, the 
clustering of DBP with other MS-related traits is largely attributable to the common 



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   
   









Elevated blood pressure (EBP) as a dichotomous trait and other MS-related traits 
 The phenotypic, additive genetic, and random environmental correlations 
between EBP (as a dichotomous variable) and other metabolic syndrome risk factors 
are presented in Table 12. The results are similar to those presented in Tables 10 and 
11. The phenotypic correlations were statistically significant (p <0.05) for all the 
variables considered, with the exception of total cholesterol, LDL, and lean body 
mass, ranged from 0.21 to 0.34 (excluding HDL for which the phenotypic correlation 
was -0.24). The genetic correlation was significant only for triglycerides (0.51). 
Given the observed patterns of genetic correlations between SBP and DBP and other 
MS-related traits, the inability to find significant genetic correlations between EBP, a 
dichotomized trait, and other MS-related traits is attributable to power loss for genetic 
analysis due to dichotomization of a continuous trait (Duggirala et al. 1997). The fact 
that the patterns of phenotypic correlations were similar to SBP and DBP and 
significant, increased sample sizes could help to partition the observed significant 
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CHAPTER FIVE: DISCUSSION 
 
Childhood obesity is associated with various metabolic abnormalities, and it 
increases the risk of adult obesity and its correlated diseases. For example, childhood 
obesity is a leading cause of pediatric hypertension (Sorof and Daniels 2002; Din-
Dzietham et al. 2007; Forrest and Leeds 2007; Genovesi et al. 2008; Ostchega et al. 
2009). However, there is limited information about the genetic influences on childhood 
elevated blood pressure as well as potential common genetic influences on blood 
pressure and various metabolic syndrome-related traits (e.g., obesity). Therefore, using 
a Mexican American Children cohort, the major goal of this study is to address the 
following issues: (1) examination of various metabolic syndrome-related traits in 
Mexican American children; (2) determination of genetic influences on blood pressure 
measures; and (3) verification of common genetic influences affecting both blood 
pressure and metabolic syndrome-related traits by partitioning their phenotypic 
correlations into genetic and environmental components.   
Although the metabolic syndrome and its components (e.g., high blood 
pressure profiles) have been well established for adults, there has been no consesus 
about such criteria (i.e., cut points to define MS risk factors) in children and 
adolescents. As stated by Steinberger et al. (2009:629), such MS criteria in children-
based studies, “have been variably adapted from adult standards with the use of age- 
and gender-dependent normal values”. Given the paucity of data on MS components 
in normal Mexican American children, this study used a similar approach (i.e., 
percentiles for age, sex, and height [in the case of blood pressure only]) to define high 
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blood pressure and other MS risk factors. The results of this study indicate that the 
occurrence of various MS risk factors in normal Mexican American children aged 6-
17 years is rather disturbing (Table 7 & Figure 15; e.g., overweight = 52%, obesity = 
33%, low HDL = 24%, prediabetes = 15%, increased abdominal obesity = 14%, and 
high blood pressure = 13%).  
The prevalence rates of various MS risk factors examined in this study varied 
by gender. In general, boys tended to have higher prevalence rates of variousMS risk 
factors compared to girls. For example, the prevalence rates of systolic blo d 
pressure, diastolic blood pressure, and elevated blood pressure varied between the 
sexes; especially boys have a higher prevalence of hypertension. Similarly, when the 
BMI is dichotomized, the prevalence of both overweight and obesity are higher in 
boys than girls, although girls exhibited slightly increased occurrence of abd minal 
obesity based on waist circumference. A high prevalence of overweight was observed 
in Mexican American adolescents, especially in males. Hypertension is observed in 
these overweight children, even after adjustment for other risk factors (Cossrow and 
Falkner 2004; Forrest and Leeds 2007).  
The occurrence of dyslipidemia (i.e., low HDL and hypertriglycerdemia) is 
slightly increased in girls compared to boys. Whereas, the rates of impaired fasting 
glucose, impaired glucose tolerance, prediabetes are found to be slightly increased in 
boys compared to girls. However, the patterns of fasting insulin and HOMA-IR (a 
measure of insulin resistance which is inversely related to insulin sensitivity) slightly 
varied by gender with an indication that girls are more insulin resistant (high fasting 
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insulin and HOMA-IR values) than boys as were validated by other studies (Cruz et 
al. 2004).  In general, Hispanic children compared with non-Hispanic whites had 
significantly higher levels of fasting insulin and are more insulin resistant th  
Caucasian children (Goran et al. 2003). The adiposity measures (except total fat mass 
and percent body fat) are higher in boys than girls. Increase in adiposity over time is 
significantly associated with increased blood pressure levels (Jafar 2009). Similarly, 
insulin resistance is correlated with high blood pressure (Ferrannini et al. 1987; 
Steinberger et al. 2009). Although boys appear to be physically active and fit based 
on activity and fitness scores, they are at higher risk for metabolic syndrome-related 
chronic conditions.    
Microalbuminuria is a measure of renal function impairment and an early 
marker of diabetic nephropathy. It is also considered as a biological marker that 
identifies individuals who are at higher risk for metabolic syndrome-related 
conditions. In this study, its occurrence is more in girls than boys. Earlier studie  
confirm the existence of strong correlations between blood pressure, serum glucose 
and microalbuminuria (Jones t al. 2002; Lee et al. 2006). Since microalbuminuria 
clusters in families, a genetic predisposition is hypothesized. Using genome-wide 
linkage analysis (after accounting for age, sex, BMI, triglycerides, and hypertension), 
a major locus was located on chromosome 20q12 that may have functional relevance 
to albumin excretion in Mexican Americans (Arar et al. 2007). 
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The few studies in the past years that have examined the secular trend in blood 
pressure have yielded inconsistent results. The Minneapolis blood pressure study on 
public school children including African Americans, Hispanics, non-Hispanic whites, 
Native Americans, and Asians aged 10-14 years found a significant increase in 
systolic blood pressure percentiles than for diastolic blood pressure from 1986 to 
1996. In the Bogalusa study on two biracial cohorts [~65% white and 35% black] 
aged 7 to 9 years. One cohort examined in 1975 and reexamined in 1981; second 
cohort in 1984 and reexamined in 1992 and both were compared, both systolic and 
diastolic blood pressure decreased by the end of study period. Another study based on 
boys and girls (representing non-Hispanic black/white or Mexican American 
ethnicity) aged 8 to 17 years participated in national surveys from 1963 to 2002 
verified increasing blood pressure trends in children. After a long period of decreas d 
blood pressure trend, since the late 1980s an elevated blood pressure (observed SBP 
or DBP ≥95th percentile) and pre-elevated blood pressure (observed SBP or DBP 
≥90th percentile but <95th percentile) increase in US children and adolescents was 
observed. In particular, rapid rise was seen in diastolic blood pressure when compared 
to systolic blood pressure. Mexican Americans have a higher prevalence of elevated 
and pre-elevated blood pressure than non-Hispanic whites. Males have a greater 
prevalence than females (Gidding et al. 1995; Luepker et al. 1999; Din-Dzietham et 
al. 2007). These results are similar to the findings observed in the current SAFARI 
participants.   
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The comparative data shown in Table 13, describes study populations 
(overweight children) of which 71% represent Mexican Americans from Los Angeles 
who are of Hispanic origin and have a family history of T2DM (Cruz et al. 2004). 
About 82% of subjects had BMI ≥95th percentile for age and gender, and ~90% of the 
participants had at least one of the components of the metabolic syndrome which 
includes abdominal obesity, low HDL cholesterol, hypertension, 
hypertriglyceridemia, and impaired glucose tolerance. For example, in this study, 
boys had significantly higher fasting blood glucose and systolic blood pressure, 
similar to the present findings of SAFARI data. In contrast, these boys exhibit d 
significantly higher diastolic blood pressure than did the girls. Overall, the insulin 









































































































To examine the relationship between blood pressure and metabolic syndrome-
related traits across ethnic groups, the results of the present study are compared with 
the data (given in Table 14) available from literature on black and white children 
(Cruz et al. 2002). They found that black children had significantly higher systolic 
and diastolic blood pressure values than white children. Black children had lower 
insulin sensitivity than white children and there were no significant differences i  
fasting insulin or fasting glucose measures. The study indicated that insulin sens tivity 
was significantly related to systolic blood pressure in both blacks and whites; hence 
ethnicity and insulin resistance were independently related to hypertension even at 
early ages. Boys had significantly higher diastolic blood pressure than girls, whereas, 
girls had higher total fat mass, percent body fat and fasting insulin values than boys; 
this finding is consistent with the present study. The systolic blood pressure for 
SAFARI children is almost similar to the whites, but the diastolic is higher than these 
two ethnic groups. Similarly, the adiposity measures are higher compared to these 
two groups. Another comparative study by Goran et al. (2002) on Caucasian, 
African-American and Hispanic youth in Los Angeles found that Hispanic children 
have lower insulin sensitivity than Caucasians and almost similar to African-
Americans. The findings of the present study signify the increasing burden of isease 
risk in SAFARI children due to elevated blood pressure, higher prevalence of 












































































Univariate genetic analyses 
 It is evident from the above discussion that, although the MS risk factor 
profiles are varied by ethnicity possibly indicating population genetic differences, 
they are often found to be correlated (e.g., obesity and blood pressure). As described 
previously, in this study, blood pressure measures exhibited significant phenotypic 
correlations with various MS-related traits including lipid, obesity, insulin and 
glucose metabolism related traits. The components of metabolic syndrome are 
complex disease conditions resulting from genetic and environmental factors 
influences and their interactions. Also, several genes are presumably involved in th  
expression of a given phenotype. For example, a number of genes are involved in the 
pathways of insulin action; hence, any genetic defect(s) in these pathways might 
contribute to insulin resistance. Likewise, any genetic defect(s) relating to the genes 
involved in pathways regulating fluid retention by kidneys and blood pressure could 
contribute to hypertension.  
 It is well established that the MS-related traits in adults such as obesity, 
T2DM, and hypertension have genetic determinants (Duggirala et al. 2000a; Pankow 
et al. 2001; Comuzzie 2002; Stern 2002; Elbein 2002; Loos and Bouchard 2003; Lin 
et al. 2006). In nondiabetic Mexican American family members, there is evidence 
that factor structures clustering the metabolic syndrome have strong genetic 
influences (Duggirala et al. 2000a, 2001). Likewise, this pediatric study reports 
strong genetic influence on MS-related phenotypes. The heritabilities of syt lic 
blood pressure and diastolic blood pressure (as a continuous variable), and elevated 
 81
blood pressure (as a dichotomous variable) are very high in this population, 
suggesting that genetic factors influence blood pressure. The high heritability 
estimates (~ 25 to 85%) are observed including almost all of the variables that have 
been examined. This genetic component of variance is attributable to additive 
polygenic effects and probably results from the action of more than one gene. It 
should be noted that, in contrast to the adult studies, the MS-related traits examined in 
children to estimate trait-specific heritability are not influenced by traditional MS-
related covariates such as smoking and alcoholism. As noted previously, the observed 
heritability estimates in this study, after accounting for the significant ovariate 
effects, are somewhat inflated since the methodological design in this study did not
allow for estimation of shared environmental influences. However, as reported in 
Appendix 3, it is interesting to note that the influence of shared environmental 
influences on adult MS-related traits in Mexican Americans appears to be minimal. 
Also, in this study, the estimates of genetic variance were attributable to additive 
genetic influences, and no attempts were made to estimate the influences of 
dominance and epistasis.   
Aside from genetic influences, the changing environmental factors such as 
poor dietary habits, reduced physical activity, and increased television viewing time 
leading to positive energy balance and significantly contribute to the increased 
prevalence rates of obesity- and metabolic syndrome-related phenotypes (Harper 
2006; Mehta 2007; Gable et al. 2007; Moore et al. 2008).  With regard to covariate 
effects, as such physical activity showed no effect on any traits, conversely pub rtal 
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status and physical fitness scores along with age and sex effects significantly 
contributed to the phenotypic variation of many traits considered for this study. 
Perhaps, the questionnaire-based physical activity measures have limitations o 
evaluate physical activity patterns efficiently. On the other hand, increased physical 
activity and fitness could lead to favorable lipid profiles and improvement in insulin 
sensitivity (Isomaa 2003; CDC 2004) which is indicated in this study as physical 
fitness score clearly affects the lipid phenotypes such as total cholester l, 
triglycerides, HDL and LDL cholesterol, and insulin measures. Another potential 
contributing factor to the development of insulin resistance in children is puberty 
(ADA 2000; Goran et al. 2003), which is supported in this study as pubertal status 
significantly affected the insulin and glucose measures in this children cohort.   
Multivaraite genetic analyses 
Since the clustering of MS-related phenotypes could be due the common genetic 
influences (i.e., pleiotropy), in contrast to a number of population-based pediatric 
studies (discussed below), the phenotypic, genetic and environmental correlations of 
blood pressure were examined after adjusting for trait-specific covariate effects and the 
phenotypic correlations were partitioned into genetic and environment (nongenetic) 
components in this family-based children cohort. The systolic blood pressure had 
significant genetic correlations with metabolic syndrome-related risk factors, especially 
fasting insulin, overweight, HOMA-IR, BMI, waist circumference, lean body mass and 
triglycerides. In a cross-sectional study by Genovesi et al. (2008) on 5 to 11 year old 
school children, both BMI and waist circumference showed significant association to 
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the risk of hypertension after adjustment for age and sex. Similar research in Mexican 
American children aged 8 to 10 years showed waist circumference as the main factor 
associated with systolic blood pressure (Colin-Ramirez et al. 2009). Waist 
circumference is used as a marker for abdominal obesity and as an important 
component of metabolic syndrome (Genovesi et al. 2008), because in this study it is 
clearly associated with blood pressure and validated by other studies where it is 
associated with several chronic diseases including central obesity and insulin resistance 
(Goran et al.2003). The significant phenotypic correlation of SBP with all these traits 
results from the genetic effects but not environmental influences as shown by this study. 
This indicates that systolic blood pressure and other metabolic syndrome-related traits 
are under pleiotropic influences in these children.  
When diastolic blood pressure is considered for bivariate genetic analyses, it 
shows similar genetic correlations with metabolic syndrome-related traits. This 
indicates that diastolic blood pressure, obesity (studies reported higher prevalenc  of 
hypertension in children with BMI ≥95th percentile [Sorof and Daniels 2002]), fasting 
insulin, HOMA-IR, triglycerides, overweight, total fat mass, BMI and percent body fat 
have a substantial degree of pleiotropy i.e., additive genetic effects that are common to 
all of these traits. In Mexican Americans, metabolic syndrome-related phenotyp s are 
influenced by a common set of genes in children and this finding is validated by several 
studies that involved Mexican American adults (Duggirala et l. 1996, 2001; Mitchell et 
al.1996). Thus, the clustering of MS-related traits due to the common genetic influences 
in adults is demonstrable in children of Mexican American ethnic background.  
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Although the bivariate analyses of SBP and DBP measures as continuous traits 
revealed significant additive common genetic influences on MS-related traits, the 
analysis of blood pressure as a dichotomous trait (i.e., elevated BP) failed to reveal 
similar patterns. This is in agreement with the general notion that the continuous traits 
are more powerful for genetic analysis compared to the dichotomized or discrete traits 
such as elevated BP and that the dichotomization of a continuously distributed trait such 
as blood pressure is associated with loss of power (Duggirala et . 1997). Even though, 
the phenotypic correlations between elevated BP and other MS-related traits are found 
to be significant in this study, none of the genetic correlations are significant; perhaps 
this is due to dichotomization of the data which usually results in the decrease of power. 
However, an increase in sample sizes compared to the present data could address this 
issue efficiently. Environmental correlations in our study appear to be not significant, 
and the lack of strong random environmental correlations between the pairs of 
examined phenotypes suggests that the basis of the observed phenotypic correlations 
are attributable mainly to shared additive genetic effects, especially phenotypic 
correlations between blood pressure and MS-related risk factors in particular, obesity, 
adiposity measures, triglycerides and insulin levels.  
Sorof and Daniels (2002) demonstrated that obesity-related hypertension is 
affected by insulin resistance, abnormalities in vascular structure and function and 
several other factors.  Several studies have recognized the possible contributi  of 
insulin resistance to hypertension, lipid disorders, and glucose intolerance (Cambien 
et al. 1987; Reaven 1988; DeFronzo and Ferrannini 1991; Ferrannini et al. 1991), 
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while others documented that the insulin variables load on the same factor as obesity 
and glucose variables, and sometimes lipid variables (Miegs 2000; Arya et al. 2002b).  
The HOMA-IR phenotype, a surrogate or indirect measure of insulin resistance b sed 
on information from fasting insulin and glucose has been frequently used in children 
to assess insulin resistance (Huang et al. 2002). Therefore, as found in this study, it is 
obvious that HOMA-IR (or insulin resistance) appears to have shared phenotypic and 
genetic effects with other traits related to metabolic syndrome. Similar conclusion 
was reached by Lin et al. (2006). In a study by Cruz et al. (2002), while examining 
blood pressure and its phenotypic relation to body composition and insulin sensitivity 
in black and white children, they found that insulin sensitivity was significantly 
associated with systolic blood pressure after adjusting for total fat and total lean mass, 
but not with diastolic blood pressure. However, previous studies have shown that in 
adults, decreased insulin sensitivity and hyperinsulinemia were correlated with blood 
pressure (Ferrannini et al. 1987; Berenson et al. 1997). The data depicting a clear 
relationship between insulin measures and blood pressure in children are scarce and 
only few represent this kind of epidemiological studies. Therefore, this study showed 
blood pressure as a continuous trait exhibited significant genetic correlations with 
HOMA-IR, fasting insulin, BMI and triglycerides, and is in agreement with some 
previously conducted research (Duggirala et al 2000a; Arya et al 2002a, 2002b). 
The variance components approach used in this study assumes multivariate 
normal distribution; therefore, the issue of non-normality regarding the examined 
MS-related quantitative traits should be addressed. For this reason, outliers that a e ± 
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4 SD from the mean for a given trait were not considered for the analysis, and certain 
variables were log-transformed. After accounting for the significant covariate effects 
(age, sex, puberty, physical activity and fitness) of a given trait, the residual kurtosis 
is within normal range for all the variables considered as assessed by the computer 
program SOLAR. It is reassuring to note that the two types of bivariate genetic 
analyses, where the blood pressure is considered either as a continuous trait or a 
dichotomous trait, generate similar patterns of phenotypic relationships between 
blood pressure and MS-related traits. A similar conclusion was reached by Burke et 
al. (2000) while analyzing acanthosis nigricans, a discrete phenotype, and its 
association with diabetes-related phenotypes. This indicates that even though 
continuous traits are more informative, but sometimes dichotomous traits also 
contribute to the understanding of the severity of the disease for study comparison, 
future algorithm construction and mapping efforts. 
SAFARI data with other San Antonio family data 
To assess the extent of MS-related burden in children compared to adults, the 
already established MS profiles for the parental cohorts of the SAFARI children can 
be helpful. Therefore, some of the major findings from San Antonio Family Diabetes 
Study (SAFDS), San Antonio Family Heart Study (SAFHS), and Veterans Affairs 
Genetic Epidemiology Study (VAGES) [given in Appendix 1] that have relevance to 
the present study were compared (Courtesy: Duggirala). The data from these studies 
for comparison should be interpreted with caution since the SAFDS and VAGES 
families were ascertained on probands with T2DM. In contrast, the SAFHS families 
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were randomly ascertained without paying attention to any disease condition. The 
prevalence rates of metabolic syndrome in SAFHS baseline data (FHS1), SAFDS 
baseline data (FDS1), and VAGES are 26%, 44%, and 53%, respectively. The MS 
profiles reflect the fact that these study samples are dominated with individuals 
afflicted with MS or its components. When the heritabilities of individual components 
of MS and their related phenotypes of the SAFARI data are compared with the San 
Antonio family data (see Appendix 2) (Courtesy: Duggirala), it is evident that he 
metabolic-syndrome phenotypes are highly heritable (especially for SBP [70% vs. 
31%], DBP [70% vs. 27%], BMI [66% vs. 46%], waist circumference [66% vs. 43%], 
and albuminuria [49% vs. 30%]) in Mexican American children compared to the 
adults. The San Antonio Family Heart Study was designed to examine the genetics of 
heart disease and its risk factors in Mexican Americans who are considered at high 
risk for diabetes prevalence (Mitchell t al. 1996). The high heritabilities observed in 
Mexican American children (especially SBP and DBP) from the present study were 
confirmed when compared to the SAFHS (see Appendix 3). The heritabilities of 
SAFHS to SAFARI participants were: 18% vs. 70% for SBP, 28% vs. 70% for DBP, 
39% vs. 54% for total cholesterol, 40% vs. 78% for triglycerides, 46% vs. 69% for 
HDL, 40% vs. 49% for LDL, 18% vs. 27% for fasting glucose, 16% vs. 25% for 2-hr 
glucose, 35% vs. 45% for fasting insulin, 42% vs. 66% for BMI. These data suggest 
that the clustering of the MS traits and their genetic bases are demonstrable even in 
children who are aged only 6-17 years. 
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It should be noted that heritabilities differ during an individual life span (e.g., 
genotype by age interactions) and also among populations because of different 
genetic make-ups and sharing of environmental risk factors. However, despite these 
caveats, the present data when compared to those in adults signify the increasing risk 
due to metabolic syndrome-related traits in Mexican American children, and my of 
the components of metabolic syndrome are already present in these children by about 
11 years of age. Although SAFARI children come from the same low-income 
neighborhoods and families as of the adults, these children are at increased disease 
risk due to the nature of familial aggregation of the quantitative traits in contrast to 
the population-based data profiles. Some of the previous findings on Mexican 
American families support the idea of extending this study to localize major 
susceptibility genes influencing variation in blood pressure and other metabolic-
syndrome related traits in children. For example, chromosome 6q influences insulin 
resistance and obesity-related phenotypes in Mexican Americans (Duggirala et al. 
2001). This finding was further verified by a study by Meyre et al. (2004) in French 
families and has been replicated by a number of studies. The chromosome 7q11.23 is 
linked with the MS in SAFDS (Duggirala et al. 1996; Lehman et al. 2004); 7q31.3 is 
linked with the MS in SAFDS (Duggirala et al. 1996); 15q is linked with triglyceride 
concentration, mean arterial pressure and albuminuria in the SAFDS (Duggirala 
2000b; Bhandari et al. 2002; Lehman et al. 2002). It would be interesting to examine 
whether such findings in adult cohorts have any relevance to the ongoing epidemic of 
childhood obesity and MS in children.  
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CHAPTER SIX: CONCLUSION 
Although there are increasingly compelling data that metabolic syndrome and its 
components have strong genetic determinants, there are minimal data on the prevalence, 
nature, age of onset, and natural progression of metabolic syndrome-related 
abnormalities and their genetic basis in children, especially in Mexican American 
children. The nature of the relationship between blood pressure and metabolic 
syndrome has not been adequately explained. Given that the Mexican American 
population has the highest age-adjusted prevalence of metabolic syndrome, this study 
was performed on children to establish the precursors of the metabolic syndrome. A 
number of metabolic syndrome risk factors including hypertension, dyslipidemia, 
insulin resistance and microalbuminuria were analyzed in this study. This study 
provided an opportunity to verify whether the prevalence of metabolic syndrome-
related traits such as hypertension, microalbuminuria, waist circumferenc , fasting 
glucose, and fasting insulin were similar between children and adults of Mexican 
American population. This study demonstrated high and significant heritabilites for the 
blood pressure, as well as for independent and individual components of the metabolic 
syndrome such as elevated blood pressure, microalbuminuria, insulin resistance, lipid, 
and body composition measures. There is evidence that disorders such as obesity, 
dyslipidemia, hypertension, insulin resistance, and microalbuminuria cluster to 
constitute the metabolic syndrome. Such patterns of clustering of correlated tr its are 
partly due to pleiotropy (see Figure 2).  
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Blood pressure and metabolic syndrome-related trait variation in the Mexican 
American children are significantly different from children in other ethnic groups. The 
observed heritability estimates of these traits are higher in these children when 
compared to Mexican American adults. The relative contributions of both genetic and 
environmental influences were quantified, genes accounted for 25 to 85% (h2; e2 = 1-h2) 
of the phenotypic variation in measures of blood pressure, adiposity, lipids, 
microalbuminuria, insulin, and glucose. With regard to age, gender, puberty, physical 
fitness and other environmental covariates accounted for <45% of the total phenotypic 
variance. These results also emphasize the importance of considering genetic factors in 
epidemiological studies of metabolic syndrome-related risk factors. As demonstrated by 
the bivariate analyses, the observed phenotypic correlations between the examined MS-
related phenotype pairs (e.g., SBP and DBP with triglycerides, insulin and body 
composition) results from strong common genetic influences. For example, the total 
phenotypic correlation between these phenotype pairs is mainly contributed from 
genetic correlations (30-50%) and minimal is contributed by environmental correlati n. 
Thus, pleiotropy may underlie the observed clustering of MS risk factors in Mexican 
American children. 
An important contribution of this study is the identification of early signs or 
precursors of the MS in children, so that plans for early detection and prevention 
(e.g., behavioral intervention) of MS disease burden can be formulated and 
longitudinal studies can be performed to track individuals from childhood to 
adulthood in matters related to longitudinal risk for diseases such as T2DM and MS 
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(Steinberger et al. 2009). Another significant finding of this study is that the MS 
clustering pattern and its genetic basis found in adults is demonstrable in children, 
too. The next step of this research should be the identification of specific gene loci 
associated with variability of these traits by mapping efforts using techniques such as 
genome-wide linkage and association studies. The present study based on the 
information from SAFARI children provides an opportunity to compare the MS risk 
profiles of children and adults, and increases the proportion of genetic information to 
be extracted from the data (e.g., power to detect linkage). The results from this study 
facilitate the understanding of complex genetic and environmental influences as well 
as their interaction effects on variation in blood pressure measures in children. In 
addition, the potential common genetic or pleiotropic influences on blood pressure 
and its correlated phenotypes such as obesity are determined. Importantly, in addition 
to the observation that various MS-related in children have strong genetics 
determinants, these data demonstrated potential environmental influences (e.g., age, 
sex and their interactions, physical fitness and puberty) on blood pressure and other 
traits in the Mexican American youth. Ultimately, the findings from this study may 
contribute significantly to the development of effective strategies to prevent and treat 
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Appendix 1. Characteristics and prevalence of metabolic syndrome* among San Antonio 
adult family members participated in various studies** (unpublished data, Courtesy: 
Duggirala). 
 
Phenotype    FHS1  FDS1  FHS 2  FGS     VAGES 
N     1430  575  856  741  1395 
Mean Age (years) ± SD   38.8 ± 16.8 42.4 ± 17.2 42.5 ± 16.1 44.3 ± 17.7 52.9 ± 15.2 
Sex (% Female)    59.3  58.9  61.8  59.2  61.7 
High Triglycerides (%)*  35.6%  48.2%  31.5%  37.5%  36.1% 
Low HDL-C (%)*   37.9%  78.0%  46.5%  53.8%  77.8% 
Abdominal Obesity (%)*  46.9%  50.7%  60.5%  61.4%  68.9% 
High Fasting Glucose (%)*  17.4%  27.7%  25.8%  32.8%  78.0% 
High Blood Pressure (%)*  27.8%  34.3%  37.9%  46.8%  54.2% 
Metabolic Syndrome (%)*  26.4%  44.2%  35.9%  41.8%  53.3%  
 
*MS according to NCEP/ATPIII definition; **FHS1 = SAFHS baselin , FDS1 =SAFDS 
baseline, FHS2 = SAFHS recall-1, FGS = SAFDS/SAFGS, and VAGES  
San Antonio Family Heart Study (SAFHS), San Antonio Family Diabetes Study (SAFDS), 















Appendix 2. Heritabilities of MS-related phenotypes: The San Antonio family-based studies 
(published and unpublished data, Courtesy: Duggirala). 
 
Phenotype* h2 (%) Study  
Type 2 diabetes 53 SAFDS (baseline) 
Insulin 53 SAFDS/SAFGS 
Acanthosis nigricans 58 SAFDS/SAFHS 
Fasting glucose 23 SAFDS/SAFGS 
2-hr glucose 28 SAFDS/SAFGS 
Adiponectin 30 SAFDS/SAFGS 
Leptin 34 SAFDS/SAFGS 
SBP 31 SAFDS/SAFGS 
DBP 27 SAFDS/SAFGS 
Waist circumference 43 SAFDS/SAFGS 
Body mass index 46 SAFDS/SAFGS 
Waist hip ratio 34 SAFDS/SAFGS 
Alkaline phosphatase 27 SAFDS/SAFGS 
ALT 18 SAFDS/SAFGS 
AST 18 SAFDS/SAFGS 
BUN 31 SAFDS/SAFGS 
Bilirubin 48 SAFDS/SAFGS 
Albuminuria 30 SAFDS/SAFGS 
C-peptide 37 SAFDS (baseline) 
IL-1β 60 SAFHS 
IL-6 49 SAFHS 
TNF-α 58 SAFHS 
CCA-IMT 27 SAFHS 
C-reactive protein  27 SAFHS 
Birth Weight  68 SAFBWS 
   
   
   
    
 
SBP = systolic blood pressure, DBP = diastolic blood pressure, ALT = alanine 
aminotransferase, AST = aspartate aminotransferase, BUN = blood urea nitrogen, IL-1β = 
interleukin-1β, IL-6 = interleukin-6, TNF-α = Tumor Necrosis Factor-α, CCA-IMT = common 








Appendix 3. Components of Variance for Selected Cardiovascular Risk Factors from San 
Antonio Family Heart Study (Adapted from Mitchell t al. 1996).  
 
Variable n Measured 
Covariates 
Genetic Household Residual 
Environment 
 
Lipids and lipoproteins      
 Total cholesterol 917 .128  .392 .038 .442 
 HDL-C 916 .108  .455 .024 .413 
 HDL3-C 916 .070  .375 .042 .513 
 HDL1+2-C 916 .078  .368 .081 .473 
 LDL-C 889 .092  .401 .074 .433 
 ln(triglycerides) 917 .155  .396 0 .449 
 apoAI 807 .145  .431 .021 .403 
 apoAII 808 .136  .341 0 .523 
 apoB 807 .155  .308 .031 .506 
 apoE 805 .082  .333 .118 .467 
 LpAI 766 .177  .360 .118 .345 
 ln(Lp[a]) 906 .014  .690 .055 .241 
 LCAT activity 672 .034  .206 .114 .646 
Glucose and hormones      
 Fasting glucose 869 .092  .183 0 .725 
 2-h glucose 850 .148  .159 0 .693 
 ln(fasting insulin) 785 .035  .348 .063 .554 
 ln(2-h insulin) 765 .113  .129 .086 .672 
 ln(SHBG) 677 .327  .126 .031 .516 
 DHEAS 661 .323  .289 0 .388 
Anthropometrics and blood 
pressure 
     
 SBP 862 .308  .178 .081 .433 
 DBP 862 .146  .283 .050 .521 
 BMI 949 .137  .424 .034 .405 
 WHR 942 .304  .058 .076 .562 
 STR 944 .309  .324 .012 .355 
  









Girls health Enrichment Multi-site Studies (GEMS) Activity Questionnaire (GAQ)






less than 15 minutes 1







How to analyze physical activity questions (items 1 - 28) to obtain summary physical activity score:
multiply 
appropriate 




for all 28 
physically-
active items
divide sum of products by 
number of non-missing 
items  to produce GAQ 












< 30 minutes 0.25
30 minutes - 1 hour 0.75
1-3 hours 1.5
> 3 hours 2.5
How to analyze sedentary activity questions (items 30 - 43), to obtain summary sedentary score:
divide sum by number of 












For reference: Treuth et al 2003:534 
